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ABSTRACT 
A Tunable Hydrogel System and Pulsatile Flow Bioreactor for the Development of 
Tissue Engineered Vascular Grafts 
by 
Melissa K. McHale 
The prevalence of coronary artery disease combined with a paucity of suitable vessel 
substitutes act as driving forces for cardiovascular tissue engineering research. In this 
thesis poly(ethylene glycol) diacrylate (PEGDA) hydrogels were investigated as a 
biomaterial for tissue engineered vascular grafts (TEVG). The global objectives for the 
work were two-fold. First, a thorough characterization of the hydrogels was warranted to 
determine material properties and cell interaction characteristics. The second objective 
was to develop a pulsatile flow culture system for TEVG that was capable of achieving 
physiologically relevant fluid flow parameters. 
Bulk properties of PEGDA hydrogels formed from a range of polymer molecular 
weights and solution concentrations were characterized. Resultant materials demonstrate 
tunable stiffness and strength, and network properties that are appropriate for supporting 
viability of encapsulated cells. Human coronary artery smooth muscle cells seeded on 
top of these PEGDA hydrogels exhibit changes in attachment, proliferation, and 
morphology that can be directly correlated to the rigidity of the substrate material. In 
general, stiffer materials encourage greater attachment, a higher rate of proliferation, and 
the development of a mature, spread morphology. Finally, these responses were shown 
to be independently modulated by changing either the hydrogel material properties or the 
peptide directed bio-adhesiveness of the substrate. 
The tissue bioreactor presented in this work is capable of imparting physiological 
fluid flow (120 mL/min), shear (5-10 dynes/cm ), pressure waveforms (120/80 mmHg), 
and pulse rates (60 or 120 bpm). Cell-laden hydrogel constructs cultured for up to 8 wk 
in this system responded to mechanical stimulation with increases in cell and 
extracellular matrix (ECM) content and positive modulations to material properties. 
Though the magnitude of ECM accumulation is quite low, changes in hydrogel stiffness 
and the presence of degrading enzymes indicate that the encapsulated vascular cells are 
working towards a more biologically appropriate surrounding. Since all parameters for 
appropriate TEVG culture are not yet understood, this device will serve as an important 
tool in the development of a small diameter vessel substitute. 
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1. Introduction 
1.1 Significance of Cardiovascular Disease 
In nearly every year of the past century, cardiovascular disease (CVD) claimed more U.S. 
lives than any other single cause. The only exception was in 1918 when 28% of the 
population was infected by an unusually virulent influenza strain. In fact in recent years, 
CVD deaths have totaled more than the next four leading causes combined (cancer, 
chronic lower respiratory diseases, accidents, and diabetes mellitus). The latest report 
from the American Heart Association predicts that in 2008 CVD afflictions will be 
associated with $448.5 billion in medical costs. Coronary heart disease, which affects the 
vessels feeding the heart itself, comprises more than half of all CVD cases. In 2005 
alone, 469,000 coronary artery bypass procedures were performed in 261,000 patients.[l] 
This statistic illustrates not only the prevalence of this subset of CVD, but also indicates 
that the majority of bypass patients require two or more grafts. Multiple Or repeat 
procedures are complicated because although autologous tissues such as the saphenous 
vein and internal mammary artery are preferred bypass materials, 10% - 40% of patients 
do not have suitable harvest tissue available. [2] The reasons for excluding autologous 
transplants are various and include: size mismatch (diameter or length), pervasive 
venous/arterial disease, and exhaustion due to previous bypass surgery. [2] At present, 
there is not a sufficient non-autologous replacement material for the small coronary 
artery, despite the availability of synthetic materials as grafts for larger vessels. Synthetic 
graft failure in coronary applications motivates the investigation of tissue engineered 
alternatives. _ 
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1.2 Overview of Blood Vessel Biology 
1.2.1 Normal Structure and Function 
Blood vessels infiltrate most tissues of the body providing a means for the distribution of 
nutrients and oxygen as well as the removal waste products, and acting as a conduit for 
the cells, proteins and signaling factors of the immune system. Of the three primary 
types of vessels, arteries are the largest and most structurally robust. They function to 
carry oxygenated blood away from the heart and as a result experience the largest 
mechanical forces of the vascular system. To remain viable in this environment, arteries 
have developed a tri-layered structure as illustrated in Figure 1-1 . 
MEDIA 
Smooth muscle cells 
Elastin fibers 
Mechanical properties 
Contractility 
Figure 1-1. Structure of the Arterial Wall.[3] The inner intimal layer consists of a 
layer of endothelial cells which confers blood compatibility. Smooth muscle cells 
(SMCs) and highly organized extracellular matrix proteins in the medial layer are 
primarily responsible for mechanical functionality. The outermost layer, adventitia, 
consists of connective tissue, microvasculature, and nerves which regulate and 
nourish the tissue. 
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The innermost layer, called the intima, consists of an endothelial cell (EC) 
monolayer that provides a non-thrombogenic conduit for blood flow. Cells of the intima 
are secured to a basement membrane, which is adjacent to a thin layer of elastic fibers 
that provide flexibility and maintain the shape of this inner layer. The artery's primary 
mechanical functionality is conferred by the medial layer, which is populated by smooth 
muscle cells (SMCs) surrounded by a highly organized extra-cellular matrix. Collagen 
(mainly types I and III) contribute the majority of the tensile strength of vessel, while 
elastin fibers provide elasticity. Proteoglycans, like versican and decorin, and hyaluronan 
dictate the compressive properties and the ECM as a whole results in the vascular 
viscoelastic behavior. [4] Finally, the adventitia surrounds the artery and contains 
fibroblasts in a connective tissue permeated by microvasculature and a neuronal network 
to facilitate autonomic control of the blood vessel. 
In normal blood vessels, the endothelium provides a non-thrombogenic surface, 
providing resistance to the adhesion of platelets and inhibiting the coagulation cascade. 
The mechanism for this thromboresistance is an EC-mediated homeostasis involving 
anticoagulant, fibrinolytic, and antiplatelet factors that are either constitutively released 
or generated in response to offensive stimuli.[5] Platelet activation and adhesion are 
prohibited by secreted prostacyclin and nitric oxide, and by ecto-ADPase expressed on 
the EC surface. Anticoagulant molecules are primarily surface bound and include 
thrombomodulin, herparin-like molecules, von Willebrand factor and protein S. The 
break down of fibrin is mediated by urokinase-type plasminogen activator and tissue-
plasminogen activator (tPA), the latter of which is in turn controlled by plasminogen 
activator inhibitor-1 to maintain the homeostasis. [5] 
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1.2.2 Onset and Progression of Vascular Disease 
The accumulation of fatty deposits on the vascular wall begins in childhood but does not 
progress rapidly until damage occurs to the endothelial layer. This injury can be the 
result of several factors including elevated levels of cholesterol and triglyceride in the 
blood, high blood pressure, tobacco smoke, and diabetes. [6] Injury to the endothelium is 
accompanied by a loss of protective factors and increase in adhesive molecules, 
coagulation activators, and mitogenic factors, which rapidly lead to thrombosis, smooth 
muscle cell migration and proliferation, and atherosclerosis.[5] In atherosclerosis, lipids, 
cholesterol, platelets, calcium, and other cellular waste products build up in the vessel 
wall to form a plaque. When accompanied by the accumulation of a clot and over-
proliferating vascular cells, this diseased tissue begins to encroach on the vessel lumen 
and can block blood flow. It is this final occlusion of the vascular conduit that prompts 
surgical intervention and in many cases insertion of a vascular bypass graft. 
1.3 Current Approaches to Vascular Bypass Grafts 
1.3.1 Synthetic Materials and Their Limitations 
Synthetic materials such as polyethylene terepthalate (Dacron) and expanded 
polytetrafluoroethylene (ePTFE or Gore-Tex) work well for peripheral vascular disease 
and the treatment of vessels with diameters greater than 6 mm. [7, 8] However, these 
materials are limited to areas of high flow and low resistance[9,10] due to poor elasticity, 
low compliance[l 1] and surface thrombogenicity.[12] A mismatch of material properties 
(e.g. elasticity and compliance) between native tissues and graft materials creates local 
strain discrepancies and altered flow regimes that contribute to intimal hyperplasia at the 
site of anastomosis as the result of over-stimulated SMCs.fl 1] This thickening of the 
5 
inner layer of the blood vessel is a common cause of restenosis (i.e. re-narrowing of the 
arterial lumen). In addition, rigid grafts are incapable of storing adequate amounts of 
elastic energy during systole, and as a result have been shown to propagate less than 60% 
of this pulsatile energy in diastole.[13] The introduction of polyurethanes as synthetic 
graft materials has greatly reduced the problems associated with mismatched material 
properties since its compliance is much closer to that of native vessels. [7] Unfortunately, 
none of these materials has proven effective in small diameter applications. 
In applications of small diameter blood vessels, synthetic devices fail mainly due 
to thrombosis, which is initiated by the adsorption of plasma protein (e.g. fibronectin) to 
the material surface. Many of these proteins contain cell binding domains that allow 
platelet adhesion or thrombin activation on the surface, with the latter stimulating platelet 
activation, coagulation, and fibrinolysis. [5] The synthetic materials currently available 
do hot possess the thromboresistant qualities of an endothelium, and unfortunately 
endothelialization of implanted graft materials by cells from the adjacent native vessel is 
not sufficient (Figure 1-2). Initially SMCs migrate from the adjacent artery and begin to 
proliferate on the graft surface. This new cell layer is covered by a proliferating layer of 
endothelial cells. [14] Generally this repair is unsuccessful as over-stimulated SMCs 
cause intimal hyperplasia at the anastomosis site, resulting in mechanical failure of the 
device or restenosis of the vessel. Additionally, the slow migration of cells into the 
implanted biomaterial is quickly surpassed by an almost instantaneous protein adsorption, 
which as mentioned previously, is a trigger for thrombosis. 
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Proteins, 
Figure 1-2. Schematic Representation of Vascular Graft Healing Initiated by 
Smooth Muscle Cell Migration. Cell translocate from the adjacent artery and into 
the graft material. [14] 
1.3.2 Tissue Engineering Approaches 
An ideal tissue engineered vascular graft (TEVG) will be biocompatible, contain a 
confluent endothelium and differentiated quiescent SMCs, and provide sufficient 
mechanical properties (strength and compliance) at the time of implant to withstand in 
vivo forces and permit suture retention^ 15] Tissue engineering approaches to vascular 
graft development are varied, but in general involve the use of a scaffold in combination 
with cells and/or other biological factors in an effort to recapitulate native vessel structure 
and function. Figure 1-3 illustrates the concept of matrix remodeling over time which 
results in a more native-like tissue. [16] Most often, these constructs are cultured in vitro 
for extended periods of time before implantation in the animal, and frequently some form 
of bioreactor is used to provide mechanical stimulation during culture.[15, 17, 18] 
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Figure 1-3. Schematic Diagram of Tissue-equivalent Preparation and Maturation. 
(a) Tissue cells, (e.g. smooth muscle cells or fibroblasts) are mixed with solubilized 
biomonomers. (b) Addition of a gelation initiator entraps cells within a hydrogel 
network, (c) Over days, cells contract the network, aligning it in response to 
mechanical constraints, (d) Over weeks, cells remodel the network, resorbing the 
original biopolymer and depositing cross-linked collagen fibrils and elastic 
fibers.[16] 
1.3.2.1 Biologically Derived Scaffolds 
Collagen is perhaps the most extensively studied scaffold material. In some cases this 
protein is homogenously purified and then re-solubilized and formed into a gel, [16, 19] 
and in other instances collagen scaffolds are derived from the ECM of existing tissues 
(e.g. small intestinal submucosa) which have been processed to remove cells and other 
extraneous components.[20] In either instance, collagen gels are relatively easy to 
populate with cells, but undergo significant compaction in culture. This compaction, in 
combination with poor mechanical properties, necessitates the use of a luminal support 
structure (e.g. Dacron) to produce tissue morphologically similar to blood vessels. 
Tranquillo et al. used this contraction to their advantage and placed constructs on a glass 
mandrel to maintain internal diameter while allowing matrix rearrangement during 
longitudinal shortening to substantially increase the graft strength.[17] As the major 
constituent of vascular EMC, collagen has the potential to provide ideal conditions for 
cellular interactions and matrix remodeling. However, because of poor handling 
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characteristics and the potential for disease transmission from xenograft sources, collagen 
matrices are currently not a viable option for vascular graft materials. 
In two fairly unique cases, researchers have produced tissue engineered vascular 
grafts (TEVGs) through non-traditional means. L'Heureux et al. cultured SMCs and 
dermal fibroblasts in monolayer 7 wk and then rolled the thick layers of cells and 
associated ECM into tubes around a PTFE support. [21] The tubes were cultured in a 
bioreactor system for an additional 9 wk with ECs seeded in the final 7 d. These 
constructs had burst strengths of 2000 mmHg, similar to native arteries, but only a 50% 
patency rate after 1 wk in vivo. Perhaps the most significant drawback to this method is 
the extensive culture time (3 months) required to produce the materials, which precludes 
its use as a clinical device. In the second case, a silastic tube was inserted into the 
peritoneal cavities of rabbits and rats and in 2 wk, avascular tissue tubes had formed. [22] 
When the grafts were implanted in the aorta they showed evidence of active remodeling 
arid 68% remained patent for 4 months. Interestingly, these materials contained 
significant amounts of elastin, which is known to be important in vascular tissues but 
notoriously difficult to produce in TEVGs.[22] It is not obvious a priori that grafts 
cultured in humans would develop similarly, but the potential for an autologous cell 
population is very attractive. 
1.3.2.2 Synthetic Scaffolds 
Perhaps a logical first step in trying to tissue engineer a small diameter blood vessel is to 
modify the materials already in use as vascular implants in order to make them less 
thrombogenic. In attempt to do this, several researchers have seeded endothelial cells on 
commercially available substrates such as Dacron[23, 24] and ePTFE[25] and allowed 
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the cells to grow to a confluent monolayer before implantation. ECs on the ePTFE 
substrate provided 68% patency in peripheral implants. [25] However, these strategies 
generally employ adsorbed matrix coatings to mediate cellular attachment to the synthetic 
surface and these coatings are known to spontaneously detach under flow conditions. 
Denudement results in a loss of protective endothelial cells and exposure of underlying 
thromboinductive polymer. 
Other synthetic polymers investigated for TEVG applications include poly(lactide-
co-caprolactone) (PLCL),[26] polyglycolic acid (PGA)[18] and polylactic acid 
(PLAj,[27] all of which will spontaneously degrade in culture due to hydrolysis, as well 
as co-polymers of these materials designed to help mitigate this degradation. [28-31] In 
contrast, polyethylene glycol) or PEG (discussed in detail in a following section) is not 
susceptible to hydrolysis and due to the potential for covalent modification with 
proteolytically sensitive moieties, can be designed to allow greater control of the 
degradation response.[32] 
PGA scaffolds were the first used to demonstrate significant potential for the 
development of vascular grafts in vitro.[\5] Porous PGA was seeded with SMCs and 
cultured under pulsatile conditions to create a tissue histologically similar to native 
vessels. In addition, the new tissue was minimally responsive to contractile agents 
indicating the potential for in vivo functionality. A drawback to this material is the poor 
mechanical properties of the preliminary mesh, which must be supported during culture 
to avoid adverse affects of contraction and collapse. [15] Other disadvantages to synthetic 
polymers in general include a lack of cell interaction capabilities, difficulty in processing, 
and in some cases, acidic degradation productions which can lead to tissue necrosis. 
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1.3.2.3 Biochemical Enhancements of TEVGs 
In addition to cells and scaffolds, certain types of biochemical factors have garnered 
notice for their abilities to enhance vascular graft development. Collagen[33, 34] and 
fibrin[35-37] are popular protein coatings known to enhance cell adhesion to substrates 
and previously used to attach both ECs and SMCs to synthetic graft materials. This 
method is complicated, however, by the fact that blood platelet cells will also readily 
adhere to these ubiquitous matrix proteins and, as such, these specific modifications may 
actually increase the failure of implanted TEVGs due to thrombosis. [3 5] To refine this 
technique and obtain selective cell adhesion, systematic studies of the amino acid 
sequences of various ECM proteins have produced the minimal peptide unit required for 
recognition by cell surface receptors. [3 8-42] 
It is now widely known that the integrin binding sequence Arg-Gly-Asp (RGD) 
derived from fibronectin will bind multiple cells types[43] (including platelets), but that 
other short peptide sequences like YIGSR or IKVAV from the basement membrane 
protein laminin will selectively bind ECs and elicit no reactivity from circulating blood 
cells.[38, 40, 44-48] Jun et al. and Massia et al. have reported the modification of 
polymeric materials with YIGSR peptides to generate a significant increase in endothelial 
cell adhesion, spreading, and migration compared with the unmodified material. [40, 44, 
45] In the first study, incorporation of a PEG linker yielded surfaces that were virtually 
resistant to platelet adhesion. [45] As another example, the peptide VAPG was shown to 
selectively bind SMCs but not ECs, fibroblasts, or platelets when covalently attached to a 
PEG hydrogel.[39] SMC adhesion was followed by extensive cell spreading, with both 
responding to the ligand in a dose dependent manner. These results have important 
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implications in the creation vascular graft materials which provide selection cell 
incorporation by are also thromboresistant. 
By similar methods (i.e. systematic amino acid analysis of ECM proteins), peptide 
sequences susceptible to cell secreted proteases, such as the matrix metalloproteinases or 
MMPs, have been identified and incorporated into tissue engineered substrates.[32] 
These peptides (and thus the engineered matrix they are conjugated to) can be degraded 
by cells via expression and activation of specifically targeted enzymes such as plasmin, 
collagenases, and elastases. As a result degradation can be systematically incorporated 
into otherwise inert materials, like PEG, by evaluating the reaction kinetics and precisely 
controlling the scaffold formulation. 
Other biochemical mediators, including various cytokines, are commonly added as 
media supplements when culturing vascular graft cells. These include ascorbic acid 
(vitamin C), transforming growth factor beta (TGF-P) and insulin, which have all been 
shown to stimulate collagen synthesis by vascular SMCs.[16] In addition, collagen 
crosslinking agents such as lysyl oxidase[49] or ribose[50] can be added as a media 
supplement to improve the mechanical properties of TEVGs through ECM stabilization 
and organization. In some instances, the enzymatic activity of lysyl oxidase has been 
provided cohstitutively by transfected SMCs.[51] Platelet derived growth factor (PDGF) 
is a SMC mitogen and is sufficient transform them from a contractile phenotype, but has 
no influence on ECs in the quiescent state. [52] Though vascular endothelial growth 
factor (VEGF) is probably best known for its roles in fetal development and 
ahgiogenesis, it is also a potent EC mitogen. This protein further impacts the vascular 
system by inducing the production of vasoprotective molecules such as nitric oxide and 
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prostacyclin, which prevent platelet aggregation and leukocyte adhesion in addition to 
maintaining SMCs in a quiescent state. [52] Consideration must be afforded to all of 
these factors and more, when designing the optimal strategy for developing a TEVG. 
1.4 Biomimetic Poly(ethylene glycol) Hydrogels 
PEG has several properties which make it desirable for use as a vessel replacement 
material. It is known to be relatively inert due to an intrinsic resistance to protein 
adsorption and cell adhesion[53], which reduces the risk of thrombosis and neointimal 
hyperplasia common in other synthetic materials. Furthermore, this polymer can be 
chemically functionalized to have very specific cell interaction moieties including 
adhesion ligands and segments capable of undergoing cell mediated degradation. [32] 
Proteins or growth factors, such as those mentioned in the previous section, can be 
covalently immobilized in a PEG scaffold while maintaining appropriate function. [54] 
This is a significant advantage because it means that the biochemical factor does not have 
to be continuously replenished in culture media and instead has prolonged activity, due in 
part to decreased cellular internalization. 
Acrylated PEG mixed with a photoinitiator (2,2-dimethoxy-2-phenyl-acetophenone) 
is easily polymerized into a hydrated gel upon exposure to long wavelength UV light (10 
mW/cm2,365 nm) in a process which is amenable to cell encapsulation[55]. A schematic 
representation of a biomemitic PEG-based hydrogel is shown in Figure 1-4. The low 
viscosity of PEG precursor solutions means that they are readily formed into various 
geometries, including tubular structures representative of blood vessels. 
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Figure 1-4. Photopolymerization of a Biomimetic PEGDA Hydrogel. Acrylated 
polymer and functionalized polymer conjugates are made into a hydrated solid 
upon exposure to long wavelength UV light in the presence of a photoinitiator. This 
process is compatible with cell encapsulation and the low viscosity of the prepolymer 
solution makes it amenable to molding into various geometries. 
Previous studies have shown the structure of this network to be dependent on the 
composition of PEG formulation in terms of polymer molecular weight and 
concentration.[56, 57] Properties of the hydrogel network, including water content and 
number average molecular weight between crosslinks (Mc), ultimately determine the 
network mesh size (Q and thereby influence the diffusive properties of the material. 
Since the mechanical properties of hydrogels are dependent on the same factors[58], the 
relationship between mechanical properties and mesh size has been explored to more 
fully characterize these materials (current work). 
PEG hydrogel properties are predicted to have graded affects on cellular function 
since recent work indicates that cells actively sense and respond to their substrates, 
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especially modulations in elastic modulus or rigidity. [5 9] Because this hydrogel exhibits 
tunable material properties, there is great potential for its use in fundamental analysis of 
cell-material interactions, as well as the opportunity to tailor vascular graft substrates for 
mechanical conditioning. 
1.5 Role of Mechanical Stimulation in Developing Vascular Substitutes 
1.5.1 The Biological Mechanisms for Cellular Response to Mechanical 
Environment 
Blood vessels reside in a dynamic environment which is continually modulated by fluid 
forces such as shear, pressure, and strain. In humans the magnitudes of these forces vary 
from vessel to vessel, but in general arterial shear is 15-25 dyn/cm2 and venous is 4-5 
dyn/cm .[60] The strain in the blood vessel wall ranges from 5 - 10%[61, 62] depending 
on vessel type and patient age/health, and the conventional value for adult blood pressure 
averages 100 mmHg and varies 20 units above and below this value. On a cellular level, 
this mechanical stimulation results in the initiation of various signaling pathways 
directing everything from cytoskeletal rearrangement and migration to programmed cell 
death. [63] Examples of proposed stretch-induced pathways are shown in Figure 1-5. 
The transmission of mechanical forces through the ECM and into cells occurs by a 
number of different mechanisms. Integrins, ion channels, G-coupled proteins, and growth 
factor receptors[52] all act as sensors for even small changes in force and initiate the 
transduction of this signal to the nucleus through secondary signaling cascades including 
PKC, Src, cAMP, FAK and MAPK.[52] The biological affects of these forces on 
vascular cells have been studied in both two- and three-dimensional experiments, and 
have significant implications for TEVG development as discussed below. 
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Figure 1-5. Pathways of Mechanical Stretch Transduction in Vascular Cells. 
Mechanical forces may act on a/B heterodimer integrins and could activate 
nonreceptor membrane tyrosine kinases including c-Src*. Activated c-Src* may 
stimulate FAK autophosphorylation, allowing association of the Shc-Grb2-Sos 
complex and downstream activation of MAP kinase. MAP kinase may simulate 
growth or protein synthesis via activation of S6 kinase (S6K). Alternatively, stretch 
acts on unknown stretch receptors (STR) that stimulate the renin-angiotensin 
system, leading to the production of Ang II (All), which in turn acts on G-protein 
coupled receptors. Autocrine production of growth factors including PDGF may 
activate tyrosine kinase receptors (R TyK). [63] 
1.5.1.1 Response of Cells to Strain and Shear in 2D Culture 
Vascular cells cultured in monolayer on distensible substrates have been subjected to 
cyclic strain and shown to produce significantly more ECM than static controls. [64-66] 
In ECs strain also promotes migration and tube formation reminiscent of 
angiogenesis.[67] A study by O'Callaghan and Williams demonstrated increased activity 
of MMP2 by SMC in cyclic strain which could potentially provide a means of 
restructuring a TEVG during culture.[65] 
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Fluid shea- forces have also been implicated in a number of biological responses by 
SMCs including migration and orientation[68], production of NO[69] and even 
modulation of intracellular pH.[70] In addition, orbital shear stress increased SMC 
proliferation and induced the normally contractile cells to acquire a synthetic phenotype. 
The authors surmised that these effects were mediated at least in part by the extracellular 
signal-regulated protein kinase 1/2 (ERK1/2) pathway based on shear-induced 
phosphorylation of ERK1/2.[71] This study mimics mechanically induced intimal 
hyperplasia that would result when SMCs are suddenly exposed to fluid shear forces after 
injury to the endothelium. Importantly, the authors note clinical relevance by suggesting 
that this aberrant phenotype is mediated by a pathway amenable to pharmacologic 
intervention. [71] What they fail to acknowledge, however, is that this result also has 
significant implications in the design of TEVGs. 
One of the goals of vascular tissue engineering is to create a morphologically 
appropriate medial layer that will include diffuse cellularity and dense, highly organized 
ECM. To facilitate this, it has been suggested that cells of the synthetic phenotype 
should be utilized. [52] However, this strategy fails to encourage the contractile function 
of the vessel cells, which will become important upon implantation in vivo. At present it 
is not obvious if the synthetic phenotype will spontaneously reverse, so alternatively, it 
may be better to investigate whether certain growth factor cocktails would induce SMC 
proliferation and ECM production without a loss of the contractile functionality. 
Drawing definitive conclusions is difficult; especially since it is still unclear how 2D 
studies like this one relate to 3D culture, and because seemingly contradictory 
experiments with explanted arteries indicate that endothelial dehudement (i.e. exposing 
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SMCs to shear forces) results in appreciable tissue deterioration and wall cell death not 
otherwise observed for intact controls. [72] 
A large number of studies have also investigated the affect of shear on endothelial 
cells. Mclntire and colleagues have spent over two decades elucidating this relationship, 
more recently with the use of a custom parallel plate flow chamber.[73] Their work has 
demonstrated that shear forces result in changes in EC morphology and orientation[74, 
75], and metabolism[76, 77]. The endothelium initiates a protective response to altered 
shear regimes as evidenced by increases in antiaggregatory (NO[78], prostacyclin[79, 
80]), and profibririolytic (tissue plasminogen activator[80]) factors and a decrease in the 
mRNA levels for a SMC mitogen. [60] Microarray studies analyzing cDNA from 
stimulated cells have provided an abundance of potential gene targets for endothelium 
therapy applications[81] and tools for extending basic understanding of EC response 
mechanical stimuli. [82] 
Though the exact relationship between the responses of cells on these 2D substrates 
and those encapsulated in a 3D scaffold is not presently clear, it is evident that vascular 
cells are sensitive and highly responsive to their mechanical environment. As illustration, 
recent DNA microarray analysis of co-cultured ECs and SMCs subjected to physiological 
shear (12 dyn/cm2) for up to 24 h found differential expression of an astounding 1151 
genes.[83] These data allude to the magnitude and complexity of cellular responses to 
applied mechanical stimuli and reiterate the importance of considering all aspects of the 
native vessel environment when attempting to recapitulate synthesis of new vascular 
tissue. 
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1.5.1.2 Effect of Applying Mechanical Stimulation during TEVG Culture 
Blood vessels are exposed to mechanical force during much of vasculogenesis and 
throughout the tissue's life, so it therefore seems logical that de novo synthesis of TEVGs 
may also benefit from similar stimulation. [15] This hypothesis has been supported by the 
positive effects of in vitro cyclic strain and physiological shear on SMC differentiation 
and ECM production and organization described previously, and as a result a number of 
biomimetic bioreactors have been developed. [2,49] The primary goal of these systems is 
to improve graft mechanical properties by stimulating the accumulation of a functional 
ECM.[49] 
In a number of cases, cyclic distension has been employed for culture of medial layer 
equivalents.[15,17,19] Typically, cell seeded constructs are cultured over silicone 
tubing or a similar support device (Figure 1-6), which is inflated to produce cyclic 
distension of between 5% and 20% and a periodic rate mimetic of either adult or fetal 
pulsing conditions (60 or 165 beats per min, respectively).[15,17,19,49] The use of a 
luminal support device makes co-culture of an endothelial layer impossible and may limit 
nutrient exchange within the graft. Unfortunately, the support is necessary for many of 
these materials {e.g. collagen) because of poor mechanical properties and drastic scaffold 
compaction after synthesis. [17] 
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Figure 1-6. Sample Bioreactor Unit. An experimental bioreactor is used to impart 
cyclic strain onto cell-seeded constructs. The tubular constructs are cultured over 
thin-walled silicone sleeves that are inflated with pressurized culture medium under 
pneumatic control to produce a 10% change in the outer diameter of the silicone. 
Grafts are not in contact with flowing medium. Gas exchange takes place through 
0.2 mm syringe filters placed on the top of the bioreactor.[19] 
The results from these systems are promising. Niklason, et at. cultured PGA 
scaffolds seeded with SMCs for 8 wk under pulsatile stress and concluded that the 
resulting tissue was similar to native in terms of collagen content and burst strength.[15] 
In other work with PGA, Kim et al. applied strain at a frequency of 1 Hz and amplitude 
of 7% and increased both cell density and extracellular matrix production. [18] Elastin 
production in particular was increased 49% over static controls. Furthermore, cells at the 
surface and within the mechanically stimulated constructs showed an extremely high 
occurrence of alignment perpendicular to strain axis after 10 wk in culture. While the 
mechanical properties of tissue engineered vessels in these experiments did not approach 
those of native arteries, the dramatic effect on ECM production supports the use of this 
type of stimulation during culture of TEVGs. [18] 
Seliktar and colleagues measured circumferential tensile properties of collagen 
constructs seeded with SMCs and cultured under dynamic conditions (10% strain, 1 
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Hz).[19] Again the mechanical stimulation resulted in cell alignment and improved 
material properties. Interestingly, it also resulted in considerable alignment of collagen 
fibers within the gel, which were not seen in static controls. [19] Later worked 
determined that this ECM organization was mediated by an increase in active MMP2 
within the constructs [84], which has implications not only for this type of graft 
maturation, but also for aiding directed degradation of specifically designed substrate 
materials discussed previously. Furthermore, the authors hypothesize that even greater 
enhancement of in vitro vascular graft development will likely result from optimization 
of the dynamic culture conditions including both the amplitude and frequency of 
strain.[19] 
Perfusion bioreactors have the added advantage of serving as means for seeding ECs 
onto the luminal surface of TEVGs.[85-87] Cell attachment is accomplished either by 
circulating cells at low flow rates or using fluid pressure to force cells into the interstices 
of the scaffold. The latter method is termed cell sodding.[88] Both methods were 
investigated for an ePTFE graft functionalized with RGD and the authors report that 
while sodding improved initial attachment to the graft, there is a significant loss of cells 
due to handling during simulated implantation manipulation. [86] Perhaps the constructs 
would have benefited from continued mechanical stimulation following cell attachment 
to allow ECs to proliferate and fully cover the surface and establish more permanent 
interactions. In the Niklason study mentioned previously, after 8 wk of pulsatile 
conditioning, grafts were removed from the luminal support tubing and seeded with ECs 
under constant flow. [15] Flow was continued for an additional 2d, after which, the 
grafts were implanted and subsequently remained patent for 4 wk in vivo.[ 15] 
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While there seems to be overwhelming evidence in support of mechanical 
stimulation during TEVG development, the precise nature of this conditioning has yet to 
be determined. [5 8] Additional insight may be obtained from work with blood vessels 
that are explanted and maintained in culture. Gooch and co-workers have devoted 
significant energies to developing an ex vivo perfusion system that preserves tissue 
viability and key morphological characteristics for up to 28 days. [72, 89] Data from 
these studies suggest that vessels may be more susceptible to deterioration as the results 
of increased flow rather than pressure, and also indicate that the endothelium has 
important protective roles that may necessitate earlier EC seeding for dynamically 
conditioned TEVGs. [72] Finally, work with both neonatal and adolescent arteries 
suggest that ideal ex vivo flow conditions may be appreciably different from the in vivo 
environment. [72, 89] The exact reason for this discrepancy is unclear, but likely results 
from a failure to completely recapitulate all of the in vivo mechanical constraints. As an 
example, blood vessels are known to be maintained under longitudinal tension in the 
body, but this restraint is rarely applied for ex vivo culture. These results provide a model 
for analyzing the mechanical environment of such tissue and a platform from which to 
generate optimized matrix formulations and culture conditions for tissue engineered 
materials. In combination with previously discussed TEVG work, these studies provide 
substantial motivation for continued analysis of construct scaffold and culture conditions 
as a means of developing a more functional small diameter vascular graft. 
2. Biomimetic Poly(ethylene glycol) Hydrogels 
2.1 Introduction 
Polymers, metals, and ceramics have been widely used as materials in biology and 
medicine for many years. However, despite the applications of these biomaterials to 
thousands of medical devices, many lack the ability to properly interface with the 
biological environment and few have been engineered for optimal performance. [90] 
Hydrogels are a rapidly expanding class of materials that can be specifically designed to 
fill this void. These aqueous materials are formed from hydrophilic polymers that are 
chemically or physically crosslinked to prevent dissolution. High water content and 
biocompatibility make hydrogels attractive options for cell immobilization and for 
applications in tissue engineering, drug delivery, and bionanotechnology.[90, 91] 
When in service as cell scaffolds or as materials for tissue engineering applications, 
hydrogels must meet several broad requirements: biocompatibility, non-toxicity, and 
appropriate mechanical properties. Ideal hydrogel properties must be determined based 
on the specific tissue application and with consideration for the cell type(s) targeted. In 
general, high water content is desirable to maintain cell viability and the mechanical 
properties of the material should be able to withstand any in vitro conditioning regimes 
and in vivo forces upon implantation. In addition, the material must possess transport 
properties that allow diffusion of nutrients and waste products in and out of the 
pericellular space. [92] 
Poly(ethylene glycol) (PEG) is a popular biomaterial choice for tissue engineering 
based primarily on the polymer's good compatibility with both chemicals and biological 
environments, low toxicity, and high water solubility. [93] Because of its low toxicity, 
22 
23 
PEG has been used in cosmetics and as a stealth coating for the delivery of 
pharmaceuticals which may be otherwise unstable in the body or have poor 
solubility. [94] PEG acts as a non-fouling material meaning that it resists protein 
adsorption and as such becomes essentially invisible in biological environments -
avoiding interactions with cells and the immune system.[53] Photopolymerized PEG 
forms a solid hydrogel material upon exposure to UV light and has been biochemically 
modified for use as a substrate for a variety of cell types. [32, 57, 95-99] 
The overall goals for work in this chapter were to synthesize and characterize the 
hydrogel materials to be used in future cell applications. This included fabrication of 
PEG-diacrylate (PEGDA) hydrogels from a range of monomer molecular weights (MW) 
and in different formulations in order to thoroughly understand the bulk properties of 
available materials. Biomimetic hydrogel components were synthesized by reacting 
peptides with PEG-monoacrylate. The peptides used in these studies were designed to 
promote cell adhesion and allow controlled degradation of the hydrogel matrix. The final 
objective was to evaluate the incorporation of peptides into these materials, confirming 
the independent control of biochemical and biomechanical properties in this hydrogel 
system. 
2.2 Methods and Materials 
All materials are from Sigma-Aldrich (St. Louis, MO) unless noted otherwise. 
2.2.1 Synthesis of PEGDA and PEGDA Derivatives 
PEGDA was prepared by combining 0.1 mmol/mL dry PEG (MW 3400 Da, 6000 Da, 
10000 Da, or 20000 Da), 0.4 mmol/mL acryloyl chloride (Lancaster Synthesis* 
Windham, NH), and 0.2 mmoL/ml triethylamine in anhydrous dichloromethane (DCM) 
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and reacting under argon overnight (Figure 2-1). The solution was then mixed with 2 M 
K2CO3 (Fisher Scientific, Pittsburgh, PA) and allowed to separate into aqueous and 
organic phases. The organic phase was isolated and subsequently dried with anhydrous 
MgS04 (Fisher), and PEGDA was precipitated in diethyl ether (Fisher), filtered, and 
dried in vacuo. Successful acrylation was determined using proton NMR analysis 
(Avance 400, Bruker, Billerica, MA). 
PEG acryloyl chloride PEG Diacrylate 
Figure 2-1. PEGDA Reaction Scheme. PEGDA is synthesized by reacting 
poly(ethylene glycol) with acryloyl chloride under anhydrous conditions. 
The peptide RGDS (American Peptide, Sunnyvale, CA) was conjugated to PEG 
monoacrylate (3400 Da) by reaction with acryloyl-PEG-iV-hydroxysuccinimide (acryloyl-
PEG-NHS, Nektar, Birmingham, AL) at a 1:1 molar ratio for 2 hr in 50 mM sodium 
bicarbonate buffer, pH 8.5. The collagenase sensitive peptide sequence GGLGPAGGK 
was synthesized using Fmoc solid phase peptide synthesis and subsequently cleaved from 
the polystyrene resin by reaction with 95% trifluoroacetic acid, 2.5% deionized (DI) 
water, and 2.5% triisopropylsilane. The cleaved peptide was precipitated in ether, 
filtered, dried, and dialyzed against DI H2O. The peptide was then reacted at a 1:2 molar 
ratio with acryloyl-PEG-NHS in 50 mM sodium bicarbonate buffer for 2 hr. PEG 
modification reactions are shown in Figure 2-2. The acrylated products (PEG-RGDS and 
PEG-LGPA-PEG) were purified by dialysis, lyophilized, and stored at -20°C until use. A 
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gel permeation chromatography system equipped with UV/vis (260nm) and evaporative 
light scattering detectors (Polymer Laboratories, Amherst, MA) was used to analyze the 
resulting PEG-peptide copolymers and confirm successful conjugation. 
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Figure 2-2. Schematic Representation of the Reaction to Create Bioactive PEG 
Moieties. 
During the progress of this work, a change in the commercial practices of Nektar Co. 
led to the investigation of other sources of functionalized PEG. A product similar to 
acryloyl-PEG-NHS is acryloyl-PEG-succinimide (acryloyl-PEG-SCM, MW 3400, 
Laysan Bio, Birmingham, AL) which has the same functionalization but a minor 
modification to the linker between the PEG chain and the Af-hydroxysuccinimide reactive 
group. This modification decreases the ester half-life to 0.75 minutes in aqueous 
solutions necessitating a protocol change for conjugation reactions. Various organic 
solvents were investigated before choosing dimethyl sulfoxide (DMSO) based primarily 
on good solubility of both acryloyl-PEG-SCM and the peptides of interest. 
To create cell adhesive molecules, the commercially available RGDS was conjugated 
to acryloyl-PEG-SCM at a 1.1:1 molar ratio for 24 hr in DMSO using N,N-
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diisopropylethylamine (DIPEA) as a base. In addition an RGD peptide sensitive to 
spectrophotometric detection (GGGWGGRGDS) was synthesized using Fmoc solid 
phase peptide synthesis as described previously and then conjugated in the same manner 
as the commercial product. The collagenase sensitive peptide, GGGPQGIWGQGK, was 
also synthesized and reacted at a molar ratio of 1:2.1 with Acryloyl-PEG-SCM in DMSO 
with DIPEA as a base. As before, the acrylate derivatized products (PEG-RGDS, PEG-
WRGDS, and PEG-PQ-PEG) were purified by dialysis, lyophilized, and stored at -20°C 
until use. 
2.2.2 Photopolymerization of PEGDA Hydrogels 
Polymer solutions containing the desired concentrations of PEGDA and PEGDA-peptide 
conjugates in 10 mM HEPES buffered saline (pH 7.4, HBS) were mixed with a 300 
mg/mL solution of the UV photoinitiator 2,2-dimethoxy-2-phenyl-acetophenone 
dissolved N-vinylpyrrolidone (NVP) at a ratio of 10 ju.1 per mL polymer. The solutions 
were transferred to transparent molds and exposed to UV light (365 nm, 10 mW/cm , 
UVP, Upland, CA) for 2 min to form hydrogels. 
2.2.3 Hydrogel Network Structure Characterization 
An understanding of the physical makeup of polymeric hydrogels is important in 
determining their potential application as biomaterials. The bulk structure of these 
covalently crosslinked networks influences material properties such as strength and 
stiffness and also dictates key parameters in biological applications such as water content 
and permeability. The three most important parameters for characterizing the network 
structure of hydrogels are the molecular weight between neighboring crosslinks (M
 c), the 
polymer volume fraction in the swollen state (V2,s), and the mesh size (Q.[90] As a 
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substitute to V2,s, one may also report the water content of the material of interest, as in 
the analysis below. The parameters are obtained through application of the Flory-Rehner 
theory which assumes that a nonionic hydrogel submerged in a fluid at equilibrium is 
acted upon by only two forces: the thermodynamic force of mixing between the polymer 
chains and the fluid, and the elastic retractive force of the polymer chains. [100] Other 
important hydrogel transport parameters are the mass and volume swelling ratios, q and 
Q, with these and all previously mentioned metrics, related to one another fundamentally 
through the material crosslink density, px.[92] 
To analyze network structure and swelling characteristics, PEGDA hydrogels of four 
different molecular weights (3,400 Da, 6,000 Da, 10,000 Da, and 20,000 Da) and three 
concentrations (0.05 g/mL, 0.1 g/mL and 0.2 g/mL) were prepared in rectangular glass 
molds. Additional formulations containing 0.01 g/mL PEG-LGPA-PEG and a mixture of 
0.07 g/mL 6,000 Da PEGDA and 0.03 g/mL PEG-LGPA-PEG were evaluated in 
anticipation of their use in the bioreactor studies with cells. For each formulation, 11 mm 
diameter disks were photographed, weighed, and then placed in HBS (pH 7.4) for 48 hr 
to achieve swelling equilibrium. After this time, equilibrium swelling masses were 
recorded and more digital images acquired. The disks were then dried in a vacuum oven 
for 48 hr at which point the dry mass of each sample was obtained. Digital images were 
analyzed to calculate change in surface area with swelling, and the water content, Mc, and 
C, were calculated using the following equations:[56] 
Equation 2-1. Hydrogel Water Content 
„ .... Swell Weight -Dry Weight „, , . . 
Water Content (%) = - - -— * 100 
Swell Weight 
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Equation 2-2. Molecular Weight Between Crosslinks, Mc 
v-l 
Mc = V+- M 
n(0)J 
where Mn(o> is the number average molecular weight of the starting polymer, and Ve is the 
number of effective chains per unit volume as defined by 
Equation 2-3. Number of Effective Polymer Chains per Volume, Ve 
^-[ln(\-V2J+V2rS+JuVl] 
V=-
2,r 
2,s 
' W 
y/3 (v \ 
v 
VXrJ 
•2 
in which v is the specific volume of bulk PEG in the amorphous state (0.893 cm /g), Vi is 
the molar volume of water (18 cm3/mol), and V2,r and V2,s are the polymer fraction of the 
hydrogel in the relaxed and swollen state, respectively. A value of 0.426 was used for the 
Flory-Huggins polymer-solvent interaction parameter (u), since it was previously found 
to be constant over a range of V2,s values from 0.04 to 0.2 for PEG in water and PBS.[56] 
The hydrogel mesh size in angstroms is calculated as follows 
Equation 2-4. Mesh Size, C, 
with the average end-to-end distance of the solvent free state of the polymer calculated as 
Equation 2-5. End to end Polymer Distance 
kT=i 2CnMc 
NV2 
M 
r J 
where 1 is the bond length (1.50 A), Mr is the molecular weight of the PEG repeat unit (44 
g/mol) and C„ is the characteristic ratio for PEG (4). [101] 
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The mass swelling ratio, q, and the volume swelling ratio, Q, were calculated as 
follows 
Equation 2-6. Mass Swelling Ratio, q 
Ms q = — -
Equation 2-7. Volume Swelling Ratio, Q 
0 = 1 + ^ - 1 ) 
Ps 
with Ms and Md equal to the swollen and dry masses of the hydrogel, respectively, and pp 
and ps the densities of PEG and the solvent. Crosslink densities, px, for each formulation 
were computed as 
Equation 2-8. Crosslink Density, px 
1 
vMc 
2.2.4 Evaluation of Hydrogel Mechanical Properties 
Mechanical testing was performed on PEGDA hydrogels of the same formulations used 
in the network structure analysis above. Dog bone-shaped samples conforming to ASTM 
D638 standards were cut from pre-swelled hydrogels that had been cast in rectangular 
molds. Sample dimensions were obtained using digital calipers, and material properties 
were measured on an Instron Model 3340 materials testing device equipped with a 10 N 
load cell (Norwood, MA). System control and data analysis were accomplished using 
Instron Series IX/s software. Uniaxial strain was applied at a rate of 6 mm/min, and the 
stress-strain data collected was used to calculate the ultimate tensile strength (UTS) and 
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average elastic modulus. Modulus was defined as the slope of the linear region of the 
stress-strain curve at a reference stress of 30 kPa. 
2.2.5 Analysis of Bioactive Peptide Incorporation into PEGDA Hydrogels 
Bioactive moieties, such as the RGDS adhesive ligand, are covalently attached to the 
PEGDA hydrogel during photopolymerization. The total incorporation of these 
molecules depends primarily on two properties of the PEG monoacrylate - percent 
acrylation and conjugation efficiency. It is also reasonable to expect that PEGDA 
hydrogels that possess significantly different network structures will also incorporate 
monoacrylated-moities at different rates due to the number and presentation of acrylates 
in the base hydrogel. To characterize this phenomenon, a spectrophometric method was 
employed. 
The amino acid tryptophan, W, was conjugated to acryloyl-PEG-SCM in a reaction 
similar to the one described for the peptide RGDS above (2.2.1). L-tryptophan (Sigma) 
was reacted at a ratio of 50:1 with acryloyl-PEG-SCM in DMSO with a small amount of 
water to increase amino acid solubility. DlPEA (2 mol per mol PEG) was added and the 
reaction placed on a rocker at room temperature overnight. The reaction was then diluted 
1:1 with water and dialyzed against 1,000 MWCO regenerated cellulose to remove 
unreacted W. Following dialysis the product was frozen, lyophilized, and stored at -20°C 
until use. 
A 20 mM solution of PEG-W in diH20 was read on a Cary 50 BIO UV Vis 
spectrophotometer (Varian Analytical Instruments, Walnut Creek, CA) to obtain the 
absorbance at 280 nm (ABS28o)- The molar extinction coefficient of W (5690 M"1) was 
then used to determine the actual concentration of the solution and thereby the 
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conjugation efficiency of the reaction. The PEG-W solution was added to volumes of 
3,400, 6,000, 10,000, and 20,000 PEGDA to achieve final concentrations of 0, 1, and 2 
mM PEG-W. DMAP was added (10 uL/ mL PEGDA) and the solutions allowed to 
polymerize for 2 min in rectangular molds. Once formed, the hydrogels were soaked in 
HBS with 0.2 mg/mL sodium azide, and the soak solution changed daily for seven days. 
After seven days in HBS, the thickness of each hydrogel was measured using digital 
calipers. The ABS280 of each sample was obtained by placing the hydrogels between two 
glass slides and inserting it in the spectrophotometer. For each formulation, the 0 mM 
PEG-W specimen was used as a blank, and the thickness of the gel served as the path 
length. The ABS280 of the rinse solution from each hydrogel sample was also recorded. 
2.3 Results and Discussion 
2.3.1 Synthesis of PEGDA and PEG Derivatives 
PEGDA synthesis resulted in polymer products of 3,400, 6,000, 10,000 and 20,000 Da 
with acrylation percentages at 80% or greater based on NMR. The yield of conjugated 
product from the reaction of peptides with acryloyl-PEG-NHS and acryloyl-PEG-SCM is 
>85% by GPC analysis. For reasons not completely obvious, conjugation to acryloyl-
PEG-SCM results in a reduction of its acrylate signal from nearly 90% to less than 50%, 
which effects incorporation of these products into hydrogels (see 2.3.4 below). 
2.3.2 Characterization of Hydrogel Network Structure 
The results of the hydrogel network structure characterization are in Table 2-1. As 
expected, the materials all have high water content (85-98%) and the level of hydration 
increases with decreasing polymer concentration. Properties of the 70% mixed 
formulation of 6,000 Da PEGDA and PEG-LGPA-PEG are similar to those for the 6,000 
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Da gels, while 100% degradable PEGDA lies somewhere between the 10,000 and 20,000 
Da formulations. The 0.05 g/mL 20,000 Da formulation has a V2,s value of 0.02, which 
is just outside the allowable 0.04 for the Flory-Huggins polymer-solvent interaction 
parameter and as such the calculations dependent on this coefficient may not be 
completely accurate. However these data are included in Table 2-1 because they do not 
appear to deviate from other results. 
In general, mesh size increases with both increasing molecular weight and 
decreasing solution concentration, with molecular weight be the most influential factor of 
the two. The network spacing determined by these results varies from 25 A to 164 A and 
is sufficient for allowing the diffusion of a range biologically relevant molecules from 
glucose (-3.5 A)[102] to IgG (-55 A) [103]. The molecular size between crosslinks, Mc, 
describes the actual distance between polymerization points and takes into account the 
chain interactions that occur in these types of materials. In all cases Mc is less than the 
theoretical maximum distance M„, indicating that the polymer chains are at less than full 
extension and/or are entangled. 
The mass and volume swelling ratios, q and Q, are related to one another through the 
specific volume of the polymer, so as expected have paralleled correlations. Both are 
included in Table 2-1 for completeness and ease of comparison with external studies, 
though typically only one or the other is necessary. The much larger swelling ratios for 
20,000 Da PEGDA formulations are indicators of the significant polymer rearrangements 
that occur in these hydrogels in comparison to lower MW materials. Also telling is the 
scale of the crosslink density, px, which is an order of magnitude higher in 3400 Da 
33 
hydrogels compared to those comprised of 20,000 Da PEGDA. These results show good 
agreement with previous studies involving similarly sized PEG polymers. [104] 
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By digital image analysis, the change in hydrogel surface area from initial 
polymerization to the equilibrium swelling point was calculated. As shown in Figure 2-3, 
the most highly concentration formulations exhibit the greatest change in shape. The 
weight change over the same time period is displayed in Figure 2-4, and is not to be 
confused with the mass swelling ratio, q, which is based on the change from dry polymer. 
The percent change in weight for each formulation is greater than the change in surface 
area, but it is the dimensional change associated with hydrogel swelling that generally 
presents the most experimental relevance. For example, morphological transformations 
in progress to equilibrium must be accounted for when synthesizing materials to fit 
certain physical restraints in testing or conditioning devices. In addition, changes in the 
total surface area of a substrate result in rearrangement of factors immobilized in the 
hydrogel matrix (e.g. cell adhesion ligands). 
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Figure 2-3. Surface Area Change in Hydrogels from Synthesis to Equilibrium 
Swelling. High MW and solution concentrations result in the greatest change from 
the initial state, while low MW PEGDA/low concentration combinations actually 
cause a slight contraction of the matrix. 
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Figure 2-4. Weight Change in PEGDA Hydrogels from Synthesis to Equilibrium 
Swelling. High MW and solution concentrations result in the greatest change from 
the initial state, while low MW PEGDA/low concentration combinations actually 
cause a slight contraction of the matrix. 
2.3.3 Evaluation of Hydrogel Mechanical Properties 
The PEGDA hydrogel material properties were obtained via tensile tests conducted on 
the Instron. Evaluation of the 0.05 g/mL 20,000 Da gels was not accomplished due to the 
poor handling characteristics of these samples. As shown in Figure 2-5 below, as 
polymer molecular weight increases and/or solution concentration is decreased, the 
elastic modulus of the material decreases. This trend correlates well with the mesh size 
data discussed above, and indicates that hydrogels that possess a more open network 
structure are also less stiff. Though the relationship between polymer molecular weight 
and ultimate tensile strength is not clear, there is an increase in material strength with 
increasing solution concentration (Figure 2-6). 
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Figure 2-5. Elastic Modulus of PEGDA Hydrogels. A clear relationship between 
hydrogel formulation and stiffness was demonstrated by varying polymer molecular 
weight and solution concentration. *p< 0.05, other significant differences exist but 
are not designated here for clarity of the data. 
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Figure 2-6. Ultimate Tensile Strengths of Various Formulations of PEGDA 
Hydrogels. Materials with a range of strengths can be generated by modulating the 
polymer molecular weight and solution concentration. *p< 0.05, other significant 
differences exist but are not designated here for clarity of the data. 
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In general, longer polymer chains are known to exhibit greater strengths than those 
that possess identical chemical composition but are shorter. [105]. This higher rigidity is 
due to an increase in chain entanglements and Van der Waals interactions as the polymer 
extends under applied force. To illustrate that the PEGDA hydrogels exhibit this 
expected relationship, the UTS data for the three different solution concentrations of 
3,400 Da, 6,000 Da, and 10,000 Da hydrogels were interpolated/extrapolated to give 
equimolar formulations. Data for the 20,000 Da samples could not be accurately fit with 
linear regression since only two data points exist. The results presented in Figure 2-7 
clearly show the expected correlation between MW and polymer strength. It should be 
noted here that although either mass or mole concentrations can be used in describing 
polymer solutions, this work will continue to utilize the mass notation since it is the 
convention in the tissue engineering literature and helps relate most clearly the fraction of 
tissue scaffold occupied by synthetic matrix. 
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Figure 2-7. Hydrogel UTS in Equimolar PEGDA Concentrations. Hydrogel 
ultimate tensile strength data was extrapolated to reflect relationships between 
equimolar concentrations of different molecular weight PEGDA formulations. Data 
clearly indicate that in addition to greater solution concentration, an increase in 
PEG chain length also results in higher tensile strength. Values are computed from 
the mean UTS values of previous experiments and do not represent multiple 
measurements. 
2.3.4 Analysis of Bioactive Peptide Incorporation into PEGDA Hydrogels 
The PEG-W conjugation reaction had an efficiency of 85% as determined by ABS280 
measurements. Results of incorporation of this molecule into PEGDA hydrogels of 
different MW are included in Table 2-2. All data were corrected for the acrylation of 
acryloyl-PEG-SCM as reported by the manufacturer (85%). As expected, the percent of 
initial PEG-W crosslinked into materials that exhibit a large degree of swelling (e.g. 
20,000 Da, 0.02 g/mL) is much lower than that of those that do not swell significantly. 
This difference is due to the volume change that takes place in the transition from 
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fabrication to equilibrium. After correcting for volume change, the percent theoretical 
values are more consistent among the different samples. 
Table 2-2. Incorporation of PEG-W into PEGDA Hydrogels 
M„ (Da) 
3,400 
6,000 
10,000 
20,000 
PEGDA 
Concentration 
(g/mL) 
0.1 
0.1 
0.1 
0.1 
0.23 
0.23 
0.1 
0.1 
0.23 
0.23 
0.2 
0.2 
Initial PEG-W 
(mM) 
1 
2 
1 
2 
1 
2 
1 
2 
1 
2 
1 
2 
PEG-W: 
Acrylate 
0.03 
0.07 
0.06 
0.12 
0.03 
0.05 
0.10 
0.20 
0.04 
0.09 
0.10 
0.20 
PEG-W Incorporation 
% Initial 
45 
39 
35 
35 
27 
29 
29 
28 
19 
21 
25 
15 
% Theoretical 
46 
39 
37 
37 
29 
30 
35 
33 
22 
25 
51 
30 
However, the overall low incorporation rates (<50%) reported here were not 
expected from this hydrogel system. The PEGDA crosslinking scheme with an initiator 
of free radical polymerization is very efficient, and previous groups have reported 81-
97% incorporation of acrylated peptides. [98] This previous study was conducted with 
hydrogels of 8,000 Da PEGDA at 0.23 g/mL and used acryloyl-PEG-NHS purchased 
from Nektar, which was reacted with peptide under aqueous conditions. As shown in 
Table 2-2, higher solution concentrations actually have a negative effect on incorporation 
rate in the current study. The reason for this effect is not obvious, since increasing the 
number of acrylate groups increases the available sites for PEG-peptide attachment. Of 
note is the ratio of PEG-W to acrylates in each formulation (Table 2-2 column 3), which 
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does not exceed 0.2 indicating that the available acrylates are not being saturated, 
especially since multiple PEG chains can join at a single crosslinking site. Furthermore, 
analysis of hydrogel rinse solutions reveals that 60-70% of the initial PEG-W has 
diffused from the hydrogel. This phenomenon is not unique to PEG-W but has also been 
identified with PEG-RGDS, PEG-WRGDS, and PEG-YIGSR as well. In addition, the 
findings of this study were confirmed using a ninhydrin analysis of amino acids within 
digested hydrogel samples. [106] 
The low incorporation of PEG-peptide appears to be a direct result of a loss of 
acrylate functional groups. Prior to the conjugation reaction, NMR reveals that the 
percent acrylation of the acryloyl-PEG-SCM is >90%, which is in agreement with the 
manufacturer's analysis. Acrylation of the PEG-peptide product, however, is less than 
50%. This instability was not an issue with the PEG product purchased previously from 
Nektar, so one possibility is that the new manufacturer is producing a particularly 
unstable acrylate modification. Because a solution to this problem was not immediately 
evident, the studies in this work were conducted by correcting for the known 
incorporation rate in all materials synthesized. 
2.4 Conclusions 
In summary, this chapter presents a thorough characterization of the properties of 
PEGDA hydrogels. These analyses provide important foundational knowledge as we 
continue to explore potential applications for this hydrogel as a cell scaffold. A high 
water content and advantageous transport properties indicate that the material is capable 
of supporting encapsulated cells. These material properties, as well as the mechanical 
properties of PEGDA hydrogels were demonstrated to be highly dependent on the 
42 
formulation parameters of the gel precursor solution. Facile modification of polymer 
solution concentration or PEG chain length results in great variation in the physical 
properties of these materials. As shown in Figure 2-8 the data can be summarized to 
illustrate the effects of individual parameters, such as crosslink density, on the physical 
properties of the hydrogel. 
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Figure 2-8. Effect of Crosslink Density on Q and E. The physical properties of 
PEGDA hydrogels can generally be related through the crosslink density. Shown 
in this plot are the effects on swelling and stiffness. 
Tunable mechanical properties, including elastic modulus and tensile strength allow 
these hydrogel materials to be tailored to various tissue engineering applications. Control 
of properties such as elasticity is important in vascular graft development, since 
compliance mismatch is a known contributor to neointimal hyperplasia and graft 
failure.[107] The hydrogels studied in this work had stiffnesses approaching 400 kPa, 
which match that of the native aorta. [108] In addition our recent efforts have resulted in 
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the fabrication of materials with measured elastic moduli in the megapascal range 
(unpublished data) making them applicable to other tissues such as heart valves, cartilage, 
and bone. 
The final section of this chapter evaluates the modification of PEGDA hydrogels 
with bioactive peptides. While some of the data obtained were unexpected or seemingly 
problematic, the beneficial implications of this study are two-fold. First, two different 
quantitative assays (ABS280 and ninhydrin) were successfully employed for 
characterization of the biochemical modifications of PEGDA hydrogels. Second, the 
characterization data contained herein provides the information necessary to tailor the 
mechanical properties of these potential cellular substrates while maintaining constant 
presentation of biochemical signals such as adhesive ligands. This control is critical in 
elucidating discrete effects on cellular response and tissue development. As such, the 
utility of this hydrogel system continues to grow. Finally, the characterization data 
presented here has served as a basis for the investigation of PEGDA hydrogels as 
vascular cell scaffolds in the chapters that follow. 
3. Influence of Biomimetic Hydrogels on Vascular Smooth 
Muscle Cells 
3.1 Introduction 
In the body, cells receive mechanical cues from surrounding tissues which help modulate 
their pheriotype.[59] It is reasonable to expect, then, that cells in contact with a 
biomaterial substrate are similarly able to sense and respond to their physical 
environment. This is in fact the case, and after first being demonstrated in epithelial cells 
and fibroblasts[109, 110] the realization has now been extended to neurons and cells of 
muscle and vascular tissues, among others. [111-114] While the exact mechanisms by 
which cell sense and respond to substrate rigidity are not yet fully understood, there is 
reasonable supposition that they involve a tensegrity feedback loop. Under this 
hypothesis forces within the actin-cytoskeleton are balanced by the resistive forces of 
both microtubules and cell-ECM adhesions. [115,116] 
The studies in this chapter were designed to answer fundamental questions regarding 
the manner in which smooth muscle cells respond to mechanical cues they receive from a 
biomaterial substrate. Information obtained from cells in contact with materials of 
different stiffnesses could help predict how the development of a tissue engineered 
vascular graft could be impacted by varying the magnitude of transluminal strain or 
longitudinal tension applied during culture. Poly(ethylehe glycol) diacrylate (PEGDA) 
hydrogels with elastic moduli in the range of those used for many tissue engineered 
scaffolds (-10-100 kPa) were investigated. PEGDA substrates provide the unique 
opportunity to isolate the effects of substrate rigidity from those of integrin presentation 
by varying the concentration and/or molecular weight of base polymer while maintaining 
constant levels of the cell interaction conjugate PEG-RGDS and vice versa (Chapter 2). 
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3.2 Materials and Methods 
All materials are from Sigma (St. Louis, MO) unless otherwise specified. 
3.2.1 Hydrogel Synthesis 
PEGDA hydrogels were formed by dissolving polymer in HEPES buffered saline (HBS, 
pH 7.4) at a concentration of 0.1 g/mL. The adhesive ligand PEG-RGDS was added to 
the final concentrations specified in the individual experiments below, with these 
concentrations corrected for hydrogel swelling as discussed in Chapter 2. The solution 
was sterilized by passing through a 0.22 urn syringe filter and all successive steps carried 
out under sterile conditions. 2,2-dimethoxy-2-phenyl-acetophenone was introduced as 
the photoiniator at ratio of 10 uL per 1 mL of polymer solution and the mixture added to 
a rectangular glass mold. The solution was finally exposed to UV light for 2 min with 
periodic rotation. Resulting hydrogels were removed from the molds and allowed to 
swell in HBS for 48 h at room temperature. After swelling, hydrogels were punched (1.5 
cm) and placed in the wells of a 24-well low-attachment plate. 
3.2.2 Influence of Substrate Rigidity on Coronary Artery Smooth Muscle Cells 
To assess the influence of hydrogel mechanical properties on the behavior of human 
coronary artery smooth muscle cells (HCASMC, Cascade Biologies, Portland, OR), 
hydrogels of stiffnesses ranging from 8-108 kPa were formed using PEGDA of 3400 -
20,000 Da (characterization details in Chapter 2). HCASMC of passage 3-8 were seeded 
onto the top of the hydrogels using stainless steel seeding rings (1 cm diameter) at 
concentrations of 1,000 to 5,000 per cm depending on the assay. All experiments were 
conducted using smooth muscle cell growth media (SMGS) which consisted of Medium 
231 (Cascade) with the following supplements: 4.9% v/v fetal bovine serum (Invitrogen, 
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Carlsbad, CA), 2 ng/mL human basic fibroblast growth factor (Invitrogen), 0.5 ng/mL 
human epidermal growth factor (Invitrogen), 5 ng/mL heparin, 5 ng/mL insulin, 0.2 
Hg/mL bovine serum albumin, 100 U/mL penicillin, and 100 (xg/mL of streptomycin. 
Incubations were carried out in a 37°C humidified environment with 5% CO2. 
3.2.2.1 HCASMC Adhesion to PEGDA Hydrogels 
Adhesion of HCASMC to hydrogels of 8, 50, 80, and 108 kPa elastic modulus containing 
1 mM PEG-RGDS was determined 3 h after seeding at 5000 cells/cm2. After the initial 
incubation, samples were washed 3 times with PBS to remove any non- or loosely 
adherent cells. Trypsin-EDTA solution at 5 times the normal concentration (2.5 g/L 
trypsin, 1 g/L EDTA) was applied to hydrogels for 25 min followed by gently scraping to 
dislodge cells from the surface. Cell number was determined using a coulter counter. To 
expand this assessment to include softer gels, digital image analysis was employed. In 
this assay, the hydrogel surface was photographed under low magnification and adjacent 
view fields tiled in Adobe Photoshop to create a single image of the entire seeding area. 
All adherent cells were marked in a separate image layer, which was then counted using 
the particle analysis function in Image J (Figure 3-1). 
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Figure 3-1. Digital Image Analysis for Cells Adherent to a Hydrogel Surface. 
Overlapping images of the hydrogel surface were merged to create a single field of 
view. An image overlay containing dots in the location of adherent cells was 
counted using the particle analyzer function in Image J. 
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3.2.2.2 Effect of Stiffness on HCASMC Proliferation 
HCASMC proliferation was assessed over a period of 48 h on hydrogels of 50, 80, and 
108 kPa elastic modulus and containing 1 mM PEG-RGDS. Cells were seeded at a 
concentration of 5000/cm2 and then removed at 3 h and 48 h by trypsin-EDTA and 
scraping as described previously. Cell number was obtained using a coulter counter and 
cell doubling time, dt, was calculated as 
Equation 3-1. Cell Doubling Time 
4-1 
where x is the time interval in hours, b is the initial cell count, and c is the cell count at 
the final time point. 
3.2.2.3 Analysis of Cell Spreading on PEGDA Hydrogels 
Images of cells on hydrogels of 50 and 108 kPa elastic moduli from the proliferation 
experiment above were analyzed to determine the number of cells exhibiting a spread 
morphology after 48 h. All hydrogels contained a final concentration of 1 mM PEG-
RGDS. Results are expressed as a percentage of the total adherent cells. 
To visualize cytoskeletal components of adherent cells, representative cells on 
hydrogels of 108 and 8 kPa elastic moduli were incubated with an antibody to the focal 
adhesion protein vinculin and with phalloidin (Molecular Probes, Carlsbad, CA) which 
reacts with filamentous actin. A FITC conjugated secondary antibody (Molecular 
Probes) allowed visualization of the vinculin, while the phalloidin was conjugated to a 
rhodamine fluorophore. Fluorescent cytoskeletal components were visualized using a 
confocal microscope. 
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3.2.2.4 Influence of Adhesive Ligands on Vascular Cells 
Studies were also conducted to observe the influence of different combinations of 
adhesive peptide and hydrogel stiffness on cell behavior. In the first study, HCASMC 
were seeded at a concentration of 1000 cells per sample onto hydrogels of 108 and 8 kPa 
elastic moduli containing either 1 or 3 mM PEG-RGDS. In order to assess effects on the 
immediate attachment and spreading, samples were rinsed 2 h after seeding and then 
photographed. Cells areas were calculated by creating field of view masks in Adobe 
Photoshop followed by analysis of total cell area on the mask layer using NIH Image J 
(Figure 3-2). A low seeding density was used to prevent cell-cell interaction. Only those 
cells located completely within the view field and not in contact with other cells were 
measured. HCASMC were also seeded onto hydrogels of 108 and 8 kPa stiffness with 
either 2 or 4 mM PEG-RGDS at a higher concentration (5,000/sample) in order to 
quantify cell number using the coulter counter. After 48 h, hydrogels were rinsed and the 
cells removed using trypsin/EDTA and scraping as described previously. 
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Figure 3-2. Cell Spreading Analysis. To determine the total area of hydrogel 
surface occupied by smooth muscle cells, a mask of cell spreading was created in 
Adobe Photoshop and then analyzed by NIH Image J. Representative image is from 
a 108 kPa hydrogel with 3 mM PEG-RGDS. Scale bar is 100 urn. 
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3.3 Results 
3.3.1 HCASMC Adhesion to PEGDA Hydrogels 
HCASMC adhesion is influenced by the elastic modulus of PEGDA hydrogels with 
stiffer substrates supporting greater adhesion than softer materials containing the same 
concentration of adhesive ligand (Figure 3-3). In the range of materials tested (8 - 108 
kPa), however, only the softest material showed statistically different adhesion with an 
average of 14% of cells attaching to the 8 kPa surface compared with 40-50% for the 
other three formulations (Figure 3-4). 
. '"* •*- . V . 
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Figure 3-3. Cell Density on PEGDA Hydrogels. Representative cell area masks 
demonstrate the difference in HCASMC adhesion on stiff (left) and soft (right) 
hydrogels. Each material contains 1 mM PEG-RGDS. 
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Figure 3-4. Boxplot of Data from Cell Adhesion Experiments. There is no statistical 
difference in the fraction of adherent cells on hydrogels ranging in stiffness from 
108 to 50 kPa. However, on the softest substrate, there is a considerable decrease in 
the percentage of cells attaching to the surface (*p<0.05, ANOVA with Tukey post-
hoc). All materials were modified with 1 mM PEG-RGDS. 
3.3.2 Proliferation 
Results of the proliferation assay are shown in Figure 3-5. Over a period of 48 h, there 
was a significant increase in the number of cells on all hydrogels (student t-test, p<0.05). 
Using Equation 3-1 HCASMC doubling times were calculated as 40, 54, and 58 h on the 
108, 80, and 50 kPa substrates respectively. The data indicate that vascular cells may 
have an increased rate of proliferation on more rigid materials which is similar to trends 
reported previously. [117] 
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Figure 3-5. Proliferation of HCASMC on PEGDA Hydrogels. While cells 
proliferated on all surfaces over a 2-day period, based on calculated doubling times 
it appears that more rigid hydrogels promote a greater rate of proliferation in these 
smooth muscle cells. All materials were modified with 1 mM PEG-RGDS. 
3.3.3 Cell spreading 
Forty-eight hours after seeding, HCASMC on both 50 and 108 kPa substrates exhibit 
normal spreading morphology. As shown in Figure 3-6, there is a significant difference 
in the proportion of spread and rounded cells on the two materials. A z-test on the 
difference between the two proportions reveals that stiff hydrogels support a greater 
fraction of spread cells (pO.Ol) compared to softer materials. 
• 48 hr 
• 3hr 
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Figure 3-6. Influence of Substrate Rigidity on Fraction of Spread HCASMC. 
Attached but un-spread cells are indicated by the red circles. Stiff hydrogels 
support a greater fraction of spread cells at 48 h (z-test, p<0.01). Scale bar is 50 Jim. 
Fluorescent staining of cytoskeletal components of vascular smooth muscle cells on 
stiff and soft hydrogels further demonstrates a rigidity-influenced difference in 
morphology (Figure 3-7). Rhodamine phalloidin allows visualization of F-actin while 
the FITC-conjugated antibody highlights regions concentrated vinculin. On the stiffer 
108 kPa hydrogels, actin stress fibers are larger, more highly aligned, and anchored at 
regions of concentrated vinculin. While cytoplasmic vinculin is evident in the HCASMC 
on the 8 kPa substrate, the cell does not possess the punctuate focal adhesions present in 
cells on the stiffer material. Upon closer inspection, it is also evident that many of these 
focal contacts are highly elongated indicating adhesion maturity.[118] These results are 
in agreement with similar studies involving the growth of smooth muscle cells on 
PEGDA[117] and polyacrylamide substrates. [114] 
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Vinculin F-actin Overlay 
Figure 3-7. Cytoskeletal Differences in HCASMC Cultured on Hydrogels of 
Different Elastic Moduli. Cells on stiffer substrates are marked by punctuate focal 
adhesions and larger, more highly aligned actin filaments. Scale bars are 20 jim. 
3.3.3.1 Role of Adhesive Ligands in Substrate Influence on Vascular Cells 
Results in Figure 3-8 illustrate the effects of increasing adhesive ligand density on 
the total area of HCASMC on biomimetic PEGDA hydrogels. Trends of increasing total 
cell area with both increasing ligand density and increasing hydrogel stiffness are 
evident. For example, hydrogels of 108 kPa elastic modulus containing 3mM PEG-
RGDS have a greater cell coverage than both substrates of equal stiffness but lower 
adhesive ligand density and substrates with equal bioadhesiveness but lower elastic 
moduli (ANOVA, p<0.05). In further analysis, it was shown that on a per cell basis 
neither hydrogel modulus nor ligand density effect cell spreading (Figure 3-9), at least 
not for the range of materials tested here. The data do reveal the great heterogeneity in 
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cell spread area in all formulations of hydrogels investigated (as evidenced by outliers in 
all groups), which can also be visualized in Figure 3-11. In terms of total number of cells 
on hydrogels of varying stiffness and adhesiveness, there is again a linear correlation 
(Figure 3-10), with both increasing stiffness and ligand density supporting the adhesion 
of a greater number of cells over the 48 h evaluation period. It should be noted that, 
although no quantitative visual inspection was made, the differences among the 
individual hydrogel groups appeared qualitatively to be more exaggerated than is shown 
here. Leading to possible explanation, it was noted that cells on soft materials detach 
from their substrate very easily, while cells on rigid hydrogels are hardly affected by 
trypsin/EDTA and require significant mechanical agitation to release. In this manner, it 
is possible that the cell numbers reported for stiff materials are slightly deflated. 
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Figure 3-8. Comparison of the Influence of Adhesive Ligand Density and Hydrogel 
Stiffness on HCASMC. Increasing PEG-RGDS concentration does not appreciably 
affect the total cell area on soft hydrogels but 108 kPa gels with the higher level of 
adhesive ligand show a marked difference. * Indicates that this group is statistically 
different from all other formulations (ANOVA with Tukey post-hoc, p<0.05). 
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Figure 3-9. Spreading Area per Cell. There is no difference in the average per cell 
area spread among the four substrates evaluated (ANOVA, p>0.05). * Indicate 
outliers from these large groups of data. 
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Figure 3-10. Effects of Hydrogel Stiffness and Adhesive Ligand Concentration on 
Cell Number. A clear trend of increasing cell number with increasing concentration 
of adhesive ligand and hydrogel elastic modulus is evident. * Indicates significantly 
different from all other groups (ANOVA, p<0.05). 
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3.4 Discussion and Conclusions 
As reported previously, PEGDA hydrogels are easily modified to permit cell attachment 
and viability.[39, 98, 99, 119]. In the current work, human coronary artery smooth 
muscle cells were shown to attach, spread, and proliferate on hydrogel substrates of 
varying stiffness. Furthermore, these cellular responses were shown to be independently 
modulated by substrate rigidity and adhesive ligand density with increases in each 
parameter inducing greater cell attachment and a higher rate of proliferation. 
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Figure 3-11. PEGDA Hydrogels as a Substrate for HCASMC. Vascular smooth 
muscle cells readily adhere to PEGDA hydrogels modified with adhesive ligand. 
Cells present normal morphology 2 h post-seeding (top) and 24 h later extend 
numerous filopodia indicative of interaction with the substrate and apparent 
migratory behavior (bottom). Representative images are of cells on a 80 kPa 
hydrogel with 1 mM PEG-RGDS. Scale bars are 100 urn. 
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After noting similar results in HCASMC on polyacylamide gels coated with 
fibronectin, Peyton and Putnam[114] put forth the following mechanism as possible 
explanation of the findings (Figure 3-12). By their explanation, cells on stiffer substrates 
must exert a larger pulling force on the material to maintain a basal "pre-stressed" state. 
In order to achieve this high level of force, the cells organize more robust focal adhesions 
and assemble large, highly organized actin stress fibers. These cytoskeletal modulations 
have implications on other cellular activities, such as migration. In subsequent 
experiments on PEGDA hydrogels, the authors noted that the rate of cell migration is 
actually decreased significantly on very rigid materials due to the presumed inability for 
cells to rapidly turn over large focal contacts.[117] This mechanism is supported by the 
cytoskeletal changes demonstrated in the current study (Figure 3-7) and by anecdotal 
observations of the removal forces required to detach cells from different stiffness 
materials here (3.3.3.1) and elsewhere.[120] 
Figure 3-12. Proposed Mechanism of the Influence of Substrate Rigidity on 
Vascular Cells.[114] Feedback from mechanical cues in the cell substrate induce 
changes in focal adhesion size and composition which then further influence intra-
cellular processes such as migration. 
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In conclusion, PEGDA hydrogels of varying elastic moduli and biochemical 
composition were shown to have distinct effects on HCASMC response. This model 
hydrogel system is easily tunable and lends itself to further investigation of isolated 
mechanical and biochemical influences on critical cellular processes including migration 
and extracellular matrix production, which will ultimately affect the choice for materials 
for tissue engineered vascular grafts, among other applications. 
4. Pulsatile Flow Bioreactor Development and Analysis 
4.1 Application of Bioreactors to TEVG Culture 
As tissue engineering endeavors became more complex, moving from thin, 
approximately two dimensional structures to 3D constructs with multiple cell and matrix 
components, new challenges of in vitro culture had to be addressed. Significant 
improvements in tissue viability were accomplished by employing dynamic culture 
vessels, such as spinner flasks and rotating wall vessels, which help to increase the 
transport of oxygen and nutrients. However, with the advent of functional tissue 
engineering strategies, there is a desire to direct cell or tissue development with a 
specific, functional target as the goal.[121] Tissue engineering bioreactors, therefore, are 
specialized culture devices that provide a "controllable, reproducible, and mechanically 
active environment to study and potentially improve tissue structure, properties, and 
integration". [122] Tissue bioreactors primarily function to maintain tissue viability and 
accelerate in vitro maturation prior to implantation. In some cases, these devices are also 
used for cell seeding and to evaluate and monitor the progress of tissue maturation.il23] 
In vascular graft applications, bioreactors can be designed to study the effects of 
hydrostatic pressure, pressure wave forms, longitudinal and radial strain, flow, and shear 
stress on TEVG synthesis and culture. The culture and conditioning methods may be 
tuned to direct stem cell differentiation down vascular lineages or to regulate the 
phenotype of smooth muscle cells. Mechanical stimulation also has the potential to 
influence cell orientation and the production and organization of a tissue matrix, which 
will improve the mechanical properties of the engineered tissue. As such, bioreactors can 
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provide the stimulus necessary to develop a functional graft substitute while allowing 
evaluation of its physiological response to in vivo environmental conditions. 
4.2 System Design 
The primary goal in developing our bioreactor system was to provide a means of 
conducting large scale studies at physiologically relevant flow conditions over an 
extended culture time. The ideal system would facilitate batch synthesis of hydrogel 
constructs in a controlled manner and allow for culture of three to four experimental flow 
groups and the appropriate number of static controls. In addition to experimental time 
course and scale, other important considerations were ease handling, especially with 
regard to setup and culture media changes; minimization of contaminant events; and real-
time monitoring of flow parameters. 
The system as designed is shown schematically in Figure 4-1 and in a photograph in 
Figure 4-2. In this flow loop, culture media is pumped from a reservoir to a compliance 
chamber via a Masterflex L/S variable speed peristaltic pump. The media from the 
compliance chamber is then directed through a CellMax pulsatile pump, which 
compresses the tubing in the pump head to produce the desired pulsation and pressure 
profile. The liquid is next passed through the experimental constructs mounted on the 
interior ports of a custom glass chamber. From the sample chamber, media flows back to 
the reservoir vessel for recirculation. 
Flow rate is digitally controlled by the peristaltic pump while adjustments to the 
pressure waveform are made by altering the number of pulsatile pumps connected in 
series and/or the degree of tubing occlusion in these pumps. Alterations to mean system 
pressure are made by adjusting the occlusion in a valve located near the inlet of the media 
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reservoir. In this manner, pressure waveforms and flow rate can be varied independently. 
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4.2.1 Media Vessels and Graft Chamber 
The media reservoir and compliance chamber are standard glass storage bottles with 
screw top caps in 250- and 100-mL volumes, respectively. Bottles were modified by the 
Rice University glass shop to have inlet and outlet ports near the bottom of the vessels for 
connection to tubing. The media reservoir also possesses two upper ports for the 
attachment of 0.2 urn vent filters allowing gas exchange with the incubator environment. 
The utility of the media reservoir is self evident. In this system, the compliance chamber, 
which is essentially a volume of media with a column of air above it, serves to damp 
oscillations in the flow stream created by the motion of the peristaltic pump, which are 
also pulsatile in nature. In doing so, this noise is minimized and the control of the 
pulsing nature of fluid is limited to the CellMax pump. 
Graft samples are mounted on the interior ports of a custom glass chamber (Figure 
4-3). Similar to the media reservoir, the graft chambers also have ports for attachment of 
vent filters to allow gas exchange. The chambers are constructed from large screw cap 
bottles which were modified by an external glass company to have three pairs of ports for 
internal sample mounting and external tubing attachment. As shown in Figure 4-3, one 
end of each graft is attached to the internal glass port while the other is fixed on a nylon 
connector and a short length of flexible tubing. This adaptor allows for slight variation in 
the final length of each graft. The elasticity of the constructs acts to maintain their 
adherence to the chamber fittings during culture. The chamber reservoir is filled with 
culture media and, unlike many culture systems, [19,124] this system places experimental 
constructs directly in the path of flow allowing transmission of shear stress to luminal 
wall cells. Static controls are cultured in identical vessels with the exception of the 
connection of external ports to a flow loop. 
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Figure 4-3. Graft Chamber. The image on the left shows the hydrogel graft 
chamber connected to the flow loop. On the right is a close-up of the interior of the 
chamber illustrating the connection of the grafts (pink) to the glass ports on one 
end and tubing extenders on the other. 
4.2.2 Mechanical Components 
An important decision in the design of this system was to employ equipment that acts 
externally on tubing rather than directly on the culture media. This provides protection 
against the contamination that is frequently associated with prolonged culture times (> 72 
hr) in systems where the media contacts components of the pump apparatus. 
4.2.2.1 Pumps and Tubing 
To create the desired volumetric flow rate for culture media in the bioreactor, a 
Masterflex L/S variable speed digital peristaltic pump fitted with an L/S multi-channel 
pump head (Cole Palmer, Vernon Hills, IL) was employed. This multi-channel head 
allows for insertion of up to four flow loops in a single pump. It is also possible to stack 
two heads on the pump for the simultaneous operation of up to eight flow loops. The 
heads can be disassembled to allow insertion of the tubing as a loop rather than breaking 
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the sterile seal and feeding it through in the traditional sense. As mentioned previously, 
the peristaltic motion of this pump creates a variable pressure signal which is reduced to a 
suitable level by the compliance chamber. 
A CellMax pulsatile pump (Spectrum Labs, Rancho Dominguez, CA) compresses 
tubing to produce the desired pulsation and pressure profiles. The amount of tubing in 
the head determines the magnitude of pressure difference (AP), with a larger contact area 
resulting in a higher AP. Fluid check valves mounted on either side of the pump prevent 
back flow. These pulsatile pumps were modified to create pulses of either 60 or 120 
beats per minute (bprri), representative"of''adult and fetal heart rates, respectively. By 
applying multiple pulsatile pumps in series a physiological profile can be obtained as 
evident by the traces in Figure 4-4. 
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Figure 4-4. Bioreactor Pressure Profile. These representative pressure waveforms 
generated using the bioreactor with the pulsatile pump set to fetal (top) or adult 
(bottom) conditions. 
All tubing and tubing connectors were purchased from Cole Parmer. Various tubing 
materials were investigated before deciding on Masterflex® platinum-cured silicon L/S 
as the primary tubing material. This material is autoclavable and has a high durability. 
Unlike some tubing tested (e.g. L/S PharMed), the silicone tubing does not leach oils or 
other particles that are incompatible with sterile applications. L/S 24 tubing (ID 6.4 mm) 
provided appropriate compliance for use in the CellMax pulsatile pump. Other segments 
of the flow loop were outfitted with L/S 16 (ID 3.1 mm) or L/S 25 (ID 4.8 mm). The 
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Masterflex® platinum-cured silicon tubing did not have appropriate durability for use in 
the peristaltic pump during multi-week bioreactor studies, however. Initial investigation 
determined that this tubing was only able to withstand approximately 8 hr of continuous 
use. As an alternative, Thermo Fisher Scientific Gore High Resilience tubing style 100C 
(ID 6.4 mm, wall 2.4 mm) was purchased for long-term studies. This specialized 
material has excellent durability, lasting a minimum of 4 wk before failure. The primary 
disadvantage to this product is cost ($175/ft) and as such it was only used for the 
peristaltic pump head segment. In addition, because this is not the standard tubing 
recommended for the Masterflex pump, it does not have the appropriate adaptors for 
connection to the pump head. Metal binder clips where affixed to the tubing on either 
side of the head as substitute. In addition to providing sterile transport of culture media, 
all tubing selected for this system is also gas permeable and as such allows for exchange 
of essential CO2 from the incubator environment. 
All tubing connectors are nylon or, where available, are nylon impregnated with 
ionic silver to promote anti-microbial action. The only exception is the pressure control 
valve (stopcock) which was only available in polycarbonate. 
4.2.3 Pressure Monitoring and Data Acquisition 
A pressure transducer (Merit Medical, South Jordan, UT) placed parallel to the constructs 
in the graft chamber is used to monitor the applied pressure profile. The transducer is 
connected to a Macintosh computer via a custom-made analog-to-digital converter box. 
The single use transducers are supplied sterile and can be ethylene oxide sterilized if re-
use is desired. An in house manometer was used to calibrate the transducers with the 
acquisition software over the range of pressures used in the bioreactor studies. 
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4.2.4 Sterilization, Assembly, and Housing 
System components are sterilized by autoclave with the exception of the polycarbonate 
stopcock, which requires ethylene oxide. Loop segments are assembled in a laminar-flow 
hobd, and after assembly all tube/connector junctions are reinforced with nylon cable ties 
for added stability during application of high system pressures. All components except 
the peristaltic pump are housed in a 37 °C tissue culture incubator with 5% CO2. 
4.2.5 Forming Hydrogels as TEVG Scaffolds 
Hydrogels for bioreactor experiments are formed in UV transparent molds consisting of 
an outer plastic cylinder of OD 6.4 mm and an inner glass mandrel of diameter 3 mm 
(Figure 4-5). To facilitate fabrication of large batches of cell-seeded hydrogels, a rotating 
platform was designed and then custom built by Richard Chronister of the Rice Chemical 
Engineering Machine Shop (Figure 4-6). The device operates at 1 rpm and holds up to 
32 cylindrical samples at a time. Once the hydrogel precursor solution is loaded into the 
molds, the device is placed between two UV lamps to provide constant and equal UV 
exposure and ensure uniform polymerization. 
Figure 4-5. Tubular Hydrogels. The tubular PEGDA hydrogels are formed in 
polymerization molds (A) with an inner mandrel of 3 mm diameter and a hollow 
plastic outer cylinder of 6.4 mm diameter. The resulting construct has a geometry 
that mimics that of a blood vessel (B). 
Figure 4-6. Rotating TEVG Device. This rotating platform designed for batch 
fabrication of bioreactor constructs can accommodate up to 32 samples at a time. 
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4.3 Analysis of the Bioreactor System 
4.3.1 Flow Characterization 
Analysis of the bioreactor system began with evaluation flow parameters in sample 
chambers of two different flow loops. It was important to confirm consistency within 
and among loops in order to permit comparison system-wide. Although great lengths 
Were taken to assemble reproducible flow systems, this uniformity was not obvious a 
priori because each chamber was individually modified and all tubing cut by hand. 
Volumetric flow rate was measured at each sample port and in the transducer line for 
each loop arid was found to be similar at every location both within and among loops 
(ANOVA, p>0.05). In addition, the average difference in measured pressure between 
two ports in a chamber was 1.2% + 0.5%, or the equivalent of an average of 0.5 mmHg + 
0.2 mmHg. Based on this evaluation, the flow profiles imparted to individual samples 
within the bioreactor system were deemed consistent and reproducible. 
Flow in this system was further characterized by calculating the Reynolds number, 
Re, according to the equation 
Equation 4-1. Reynolds Number, Re 
juA 
where p is the density, Q is the volumetric flow rate, D is the internal diameter of the 
graft, [i is the viscosity and A is the internal area of the tube. In addition, using the 
Poiseuille assumption for steady flow in a pipe, the wall shear stress, xw, in cylindrical 
bioreactor constructs is defined as 
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Equation 4-2. Wall Shear Stress, TW 
" UW 
where, R is the radius. The measured viscosity of cell culture media for these 
experiments was indistinguishable from that of water ([i « 1 cps). Density was similarly 
approximated as that of water (0.993 g/cm ). Cylindrical hydrogels had a radius of 1.5 
mm as restricted by the size of the glass mandrel used for synthesis. Using these 
parameters, the Reynolds number and wall shear stress for various flow rates were 
calculated for Table 4-1 below. Of note, modulating the graft flow rate between 30 and 
160 mL/min results in physiologically relevant shear stresses[60] and Reynolds numbers 
indicative of laminar flow which is important for diffusion of nutrients and oxygen to 
three dimensional constructs. [125] 
Table 4-1. Reynolds Numbers and Shear Stresses for Various Volumetric Flow 
Rates 
Qtotai (mL/min) 
120 
240 
360 
480 
640 
*Qgraft (mL/min) 
30 
60 
90 
120 
160 
Re 
211 
421 
632 
843 
1124 
TW (dynes/cm2) 
1.9 
3.8 
5.7 
7.5 
10.1 
* Although each flow loop has three grafts, flow from the pump is split four ways 
because one line goes to the pressure transducer. 
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4.3.2 Batch Synthesis of Bioreactor Samples 
Batch fabrication of graft constructs using the rotating platform saves large amounts of 
time in experiment setup since up to 32 gels can be exposed to UV in 6 min as opposed to 
64 min. Shorter times mean that the cells are returned to culture media more quickly and 
undergo less Stress. In addition the method helps to ensure consistent mechanical 
properties among specimen. Hydrogels exposed to UV on the rotating platform were not 
statistically different in elastic modulus or ultimate tensile strength. Furthermore, the 
gelation is uniform along the length of a single gel specimen based on evaluation of 
tensile properties at three different locations on the sample. These results are in 
agreement with previous studies reporting reproducibility and uniformity in hydrogel 
fabrication[57, 96, 126-129] and provide support for the use of this batch synthesis 
method. 
4.3.3 Measurement of Transluminal Strain in Bioreactor Specimens 
The transluminal strain imparted on different formulations of PEGDA hydrogels by the 
pulsatile flow bioreactor was assessed under physiological flow conditions of 120/80 
mmHg and 120 mL/min[101] at fetal heart rates of 120 bpm. To measure radial 
distension, a Nikon Coolpix 5000 digital camera was used to image vessels undergoing 
mechanical pulsation at a capture rate of 30 frames/s. Two independent observers 
evaluated the maximum and minimum vessel distensions from the recorded images using 
the Adobe Photoshop measurement tool. Three measurements per gel were made for 
three different hydrogel samples for each formulation. The percentage strain was then 
calculated as 
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Equation 4-3. Percent Luminal Strain 
%= max~ min*100 
A™ 
where D represented the inner diameter of the vessel wall. [130] 
To relate measured strain to biomechanical properties, each construct was sectioned 
into thin rings and the mechanical properties assessed on the Instron, using a modification 
of the circumferential property testing techniques validated in Johnson et a/.[131] and 
Hiles et al. [132] Sample dimensions were obtained from digital images (inner and outer 
diameter) or using calipers (width). Custom mounting brackets provided uniaxial strain 
application at a rate of 6 mm/min for the ring-shaped hydrogels (Figure 4-7). The area of 
force application was approximated as two rectangles each with sides equal to the width 
and wall thickness of the ring. The gauge length was taken to be the outer radius of the 
ring less the wall thickness (Figure 4-7). For each gel, the measured strain was validated 
by comparison with the strain, E, estimated from application of Bernoulli's law to vessel 
dynamics, namely, 
Equation 4-4. Bernoulli Strain 
APrv 
£=-
hvE 
where AP is the peak to trough pressure rise, E is elastic modulus, rv is vessel inner 
radius, and hv is vessel wall thickness.[132] 
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Sample Dimensions 
Thickness (t) = OD - ID 
Gauge Length (GL) = OD - 1 
Width (w) 
%A im 
*F 
GL 
w 
Rectangular Approximations 
Figure 4-7. Tensile Testing Setup. The dimensions of ring-shaped hydrogel sections 
were measured as shown and the area of force application estimated as two 
rectangles. Custom mounting brackets support the test specimen, indicated by the 
arrow, in the Instron grips during mechanical testing. 
As shown in Table 4-2, a range of mechanical properties can be obtained by 
varying the formulation parameters in the PEG-based hydrogels (e.g. polymer molecular 
weight or solution concentration). Transluminal strains for the materials tested varied 
from 2.9% for the concentrated 6000 Da gel to 10.7% for the formulation containing 30% 
degradable PEGDA. This range includes the values of 5-10%, which represent in vivo 
arterial strains [61, 62, 133] and have been found to induce SMC proliferation and ECM 
production in vitro.[134] For each gel formulation, the measured strains correlate closely 
with the strains predicted by application of Bernoulli's law based on measured pressure 
profiles and experimentally obtained elastic moduli. Furthermore, because cell behavior 
has been shown to be significantly altered with changes in network crosslinking density 
77 
and modulus, the combined bioreactor-PEG construct system can be used to explore the 
impact of controlled changes in construct properties on TEVG outcome. 
Table 4-2. Transluminal Strain in PEGDA Hydrogels 
Formulation 
100mg/ml_3400Da 
100mg/ml_6000Da 
200 mg/mL 6000 Da 
100mg/ml_ 10000 Da 
200 mg/mL 10000 Da 
70 mg/mL 6000 Da + 
30 mg/mL P-LGPA-P 
Strain (%) 
Measured 
6.2 + 0.4 
6.4 + 0.5 
2.9 + 0.4 
10.9+1.3 
3.6 + 0.4 
10.4 + 0.2 
Bernoulli 
7.2 
9.5 
4.2 
10.9 
5.5 
11.3 
Modulus 
(kPa) 
92.1+2.7 
81.2 + 1.2 
140.4 + 5.3 
48.4+1.7 
76.3 + 2.0 
59.3 + 2.5 
UTS (kPa) 
67.0 + 6.7 
69.8 + 8.2 
101.7 + 12 
66.2 + 11 
69.8 + 4.3 
43.3 + 8.4 
4.4 Conclusions and Future Directions 
All of the primary goals for the pulsatile flow bioreactor system were successfully 
accomplished. The system is conducive to large scale bioreactor experiments in terms of 
both graft fabrication (using the rotating gelation platform) and long term culture. 
Careful selection of culture vessels, pumps, tubing, and connectors has made the flow 
loop relatively easy to use and, importantly, protects sterile culture media and cell-seeded 
constructs from bacterial and fungal contamination (as demonstrated by results in 
Chapter 5 of this thesis). Evaluation of the current system has shown that it is capable of 
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reproducing consistent, physiologically relevant, flow conditions and that several of these 
conditions can be independently modulated to access their affects on vascular cell 
behavior and tissue engineered vascular graft development. 
An important benefit of this bioreactor is the direct contact of engineered tissue with 
flowing culture media, which allows juxtaposed cells to sense fluid shear. This condition 
becomes very important as endothelial cells are added to the graft luminal surface since 
EC have been shown to modulate their orientation and morphology in response to shear 
stresses.[135] In addition, preconditioning with shear has been shown to increase EC 
adherence to graft surfaces[136, 137] and reduce neointimal thickening open 
implantation.[136] It is significant to note, however, that these beneficial effects on EC 
orientation, morphology, and function are observed only in laminar and not turbulent 
flow conditions. [ 13 8] 
There is one primary environmental constraint missing from the current bioreactor 
setup - longitudinal strain. In the current system, cell-seeded hydrogels are secured to 
the inner ports of the culture chamber in a relaxed state, while in vivo blood vessels exist 
with inherent longitudinal strain. [72] As a TEVG matures, this strain may become 
important in influencing the orientation of emerging collagen bundles and elastic fibers. 
The current graft chamber can be modulated to accommodate a static longitudinal strain 
by securing the ends of the PEGDA hydrogels to the sample ports. Although the 
hydrogels do not respond well to suturing, fibrous materials (e.g. sterile gauze) have been 
successfully polymerized into the ends of the polymer to allow for suturing or other 
modes fixation. The material remains integrated with the hydrogel even when the 
polymer is stretched to 120% of its original length. 
79 
A final consideration would be to adapt the pulsatile flow bioreactor to serve as a 
device for real-time monitoring of TEVG mechanical properties. One such system was 
designed to evaluate the mechanical properties of ex vivo arteries during short-term flow 
experiments.[123, 139] Another device, the ElectroForce® BioDynamic™ test 
instrument manufactured by Bose Corporation is designed for pulsatile flow culture of 
vascular constructs and uses catheter pressure transducers to provide real-time 
measurements of luminal and abluminal pressures, as well as, optical or laser 
micrometers to assess changes in outer diameter due to strain, creep, or tension. Similar 
functionality could be built into the current bioreactor system to expand its utility in 
vascular graft development. 
5. TEVG Culture in a Pulsatile Flow Bioreactor 
5.1 Introduction 
Blood vessel replacements are frequently necessary in the treatment of advanced 
atherosclerosis, aneurysmal and peripheral vascular disease, and trauma. Autologous 
saphenous veins and mammary arteries are currently the preferred graft materials. 
However, the availability of tissues of appropriate dimensions is limited[140], and donor 
site morbidity is a significant complication in these procedures. When autologous tissue 
is unavailable, synthetic materials (mainly Dacrott and polytetrafluoroethylene) are 
frequently used for the treatment of peripheral vascular disease, but their use is limited to 
high-flow/low resistance conditions[9, 10], i.e., to greater than 6 mm internal diamter 
vessels, because of their thrombogenicity, relatively poor elasticity, and low 
compliance[ll]. Tissue engineering represents a potential means to construct functional 
grafts that could be used in vascular replacement procedures where autologous tissue is 
unavailable and synthetic materials fail[141]. 
Blood vessels consist of three layers: a thin monolayer of endothelial cells, a 
medial layer composed of smooth muscle cells (SMC) embedded within a dense network 
of collagen and elastic fibers, and a loosely organized adventitial layer comprised of 
fibroblasts. Since the medial layer is the primary load bearing layer of the arterial wall, 
much of the previous research in tissue engineered vascular grafts (TEVG) has focused 
on developing a bioartificial medial layer[142, 143]. While initial results with many of 
the TEVG constructed to date are very encouraging, a number of technical hurdles 
remain before they can be considered a viable vascular replacement option[49]. The 
potential for aneurysmal failure is a significant concern, since the mechanical integrity of 
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TEVG is generally less than that of the arteries they replace and since the mechanical 
integrity of the engineered grafts may not be maintained with time. In addition, many 
TEVG studies have been plagued in the in vivo setting by thrombosis and intimal 
hyperplasia[49]. 
One approach that several investigators have taken to improve TEVG mechanical 
and biochemical outcome involves exploiting the ability of cells to sense and respond to 
mechanical stimuli. Mechanical stretching of SMC has been shown to have profound 
effects on the cell phenotype[144, 145], orientation[145], ECM deposition[146, 147], 
growth factor release[148], and mechanical properties[134, 149]. Important work by Kim 
et al. showed a 15% increase in SMC proliferation and a 49% increase in elastin content 
for polymeric scaffolds cultured for 10 weeks with cyclic strain at an amplitude of 7% 
compared to unloaded controls[134]. Additionally, the elastic moduli and ultimate 
tensile strengths (UTS) of these constructs were significantly higher in the mechanically 
stimulated group. In total, these findings provide support for the inclusion of 
physiologically relevant mechanical stimulation in the development of tissue engineered 
constructs containing SMCs. 
While the aforementioned mechanical conditioning studies have shown promising 
results in terms of increasing construct Stiffness and strength, ECM deposition, and SMC 
phenotype, none has applied a fully physiological pulsatile wave to the constructs. In the 
current work, a pulsatile flow bioreactor has been designed to allow for both 
physiological shear and pulsatile conditioning to examine the effects of these combined 
stresses oil TEVG outcome using poly(ethylene glycol) (PEG) hydrogels as a model 
scaffold material. 
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Diacrylate-derivatized PEG (PEGDA) macromers readily dissolve in aqueous 
solution, forming an optically transparent, low viscosity mixture that is 
photopolymerizable in the presence of cells[150, 151]. Thus, seamless, mechanically 
isotropic[152] cylindrical constructs with homogenously seeded cells[96, 126-129, 153] 
can be readily formed by pouring a solution of photoactive PEG macromers, cells, and 
photoinitiator into an appropriately shaped mold and applying light. In addition, PEG 
hydrogels are highly elastic, which is important in the vasculature where tissues must 
maintain their form in response to prolonged mechanical stress. PEG hydrogels also have 
tunable mechanical properties, meaning that the strain experienced by the scaffold can be 
varied independently of an applied pulsatile waveform and shear stress by changing the 
scaffold composition. Thus, the custom-built reactor combined with PEG-based 
hydrogels creates a versatile system in which strain amplitude, pulse shape, pulse 
frequency, and shear can be varied independently and their roles in vascular development 
examined. 
Reported in this chapter are the results of three studies using the pulsatile flow 
bioreactor. The studies explore the effects of dynamic culture at physiological and sub-
physiolgoical conditioning regimes and two different cell types - mouse 10T1/2 smooth 
muscle progenitor cells (10T1/2) and human coronary artery smooth muscle cells 
(HCASMC). In addition the effects on the hydrogel matrix degradation potential are 
investigated by varying the content of two covalently incorporated peptides 
(GGLGPAGGK and GGGPQGIWGQGK) that are sensitive to cleavage by matrix 
rhetalloproteinases (MMP). [154-156] 
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Table 5-1 summarizes the parameters for each of the bioreactor studies. Included 
are the cell type and initial seeding density, the hydrogel formulation giving ratios of 
PEGDA to degradable polymer and the cell adhesive moiety PEG-RGDS. Listed next 
are the specific flow parameters achieved in each study including flow rate (mL/min), 
pressure differential (mmHg), pulse rate (bpm), and shear stress (dynes/cm ). 
Table 5-1. Experimental Parameters for Bioreactor Studies 
Study 
10T1/2 
LGPA 
SMC 
LowPQ 
SMC 
High PQ 
Cell Type & 
Density 
mouse embryonic 
progenitor 
1.3xl06/mL 
HCASMC 
10xl06/mL 
HCASMC 
8xl06/mL 
Hydrogel Formulation 
70%6kDaPEGDA 
30% PEG-LGPA-PEG 
2.8 mM PEG-RGDS 
70% 6 kDa PEGDA 
30% PEG-PQ-PEG 
2.8 mM PEG-RGDS 
30% 6 kDa PEGDA 
70% PEG-PQ-PEG 
2.8 mM PEG-RGDS 
Flow Parameters 
120 mL/min 
110/70 mmHg 
120 bpm 
7.5 dynes/cm2 
40 mL/min 
45/5 mmHg 
120 bpm 
2 dynes/cm2 
60 mL/min 
55/15 mmHg 
120 bpm 
4 dynes/cm2 
Time 
Course 1 
8wk 
(0,4,8) 
5wk 
(0,5) 
8wk 
(0,4,8) 
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5.2 Methods and Materials 
All materials were obtained from Sigma (St. Louis, MO) unless otherwise noted. 
5.2.1 Synthesis of PEGDA and PEG Derivatives 
Poly(ethylene) diacrylate (PEGDA) and bioactive PEG derivates were synthesized as 
described previously in detail (2.2.1). Briefly, PEGDA of molecular weight 6000 Da was 
synthesized by reaction PEG with acryloyl chloride and triethylamine in anhydrous 
conditions. The solution was washed with K2CO3 and the organic phase dried with 
MgSOV before precipitation in diethyl ether. The MMP sensitive peptide sequences 
GGLGPAGGK[154] and GGGPQGIWGQGK[155, 156] were formed using solid phase 
peptide synthesis with standard Fmoc-chemistry, and were conjugated, along with the 
commercially available RGDS, to monoacrylated PEG. In the 10T1/2 LGPA study this 
reaction was carried out under aqueous conditions with acryloyl-PEG-NHS and for 
HCASMC PQ studies the peptides were reacted with acryloyl-PEG-SCM in organic 
buffer. 
5.2.2 Cell Culture 
All cell expansion procedures and bioreactor experiments were carried out in a 37°C 
humidified environment with 5%C02. Cell culture media was replaced every two to 
three days. 
5.2.2.1 10T1/2 Smooth Muscle Progenitor Cells 
In the first study, mouse embryonic 10T1/2 smooth muscle (SM) progenitor cells (ATCC, 
Manassa, VA) were expanded in monolayer culture between passages 4-6. Prior to 
encapsulation within hydrogels, cells were maintained in Eagle's Minimum Essential 
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Medium (MEM, ATCC) supplemented with 10% heat-inactivated fetal bovine serum 
(FBS) and without the use of antibiotics/antimycotics. This media maintains the 
undifferentiated state in these progenitor cells. [157] Once in bioreactor experiments, 
10T1/2 cells were cultured in MEM supplemented with 10% FBS, 10 ng/mL TGF-pl 
(R&D systems, Minneapolis, MN), 10 ^ g/mL insulin, 50 mM L-ascorbic acid, 10 |ag/mL 
ciprofloxacin, 100 mU/mL penicillin, 100 mg/L streptomycin, and 0.25 |j.g/mL fungizone 
(Gibco, Carlsbad, CA). The cocktail of growth factors and L-ascorbic acid added to the 
media was selected for two reasons. First, 10T1/2 SM progenitor cells have been shown 
to display a smooth muscle cell phenotype when cultured in the presence of TGF-pi. In 
addition, smooth muscle cells have been shown to increase both collagen and elastin 
production relative to basal levels when in the combined presence of L-ascorbic acid, 
TGF-pl, and insulin.[158] 
5.2.2.2 Human Coronary Artery Smooth Muscle Cells 
Human coronary artery smooth muscle cells (HCASMC, Cascade Biologies, Portland, 
OR) were used between passages 3-8 and expanded prior to experiments in smooth 
muscle cell growth media (SMGM) which consisted of Medium 231 (Cascade) with the 
following supplements: 4.9% v/v fetal bovine serum (Invitrogen, Carlsbad, CA), 2 ng/mL 
human basic fibroblast growth factor (Invitrogen), 0.5 ng/mL human epidermal growth 
factor (Invitrogen), 5 ng/mL heparin, 5 ug/mL insulin, 0.2 ug/mL bovine serum albumin, 
100 U/mL penicillin, and 100 ng/mL of streptomycin. This medium served to maintain 
the HCASMC in the growth or proliferative phase. After 4 wk in culture during the SMC 
High PQ study, the culture medium in one flow loop was changed to smooth muscle cell 
differentiation media (SMDM) which consisted of Medium 231 with 1% v/v fetal bovine 
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serum and 30 ng/mL heparin. The lower serum concentration and heparin 
supplementation are known to induce differentiation to the contractile phenotype in these 
cells[ 159-161]. Examples of the different effects of the two media types are shown by 
immunocytochemical analysis of HCASMC cultured on tissue Culture polystyrene 
(Figure 5-1). Of note are significant increases in the expression of the contractile protein 
smooth muscle a-actin (SM a-actin) and the SM a-actin associated protein calponin. In 
addition while a majority of cells in SMGM stain positive for proliferating cell nuclear 
antigen (PCNA), indicating cells in G-phase of mitosis, few if any proliferating cells are 
found in SMDM. 
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Figure 5-1. Expression Differences between HCASMC in SMDM and SMGM. 
Differentiation media promotes expression of the contractile proteins SM a-actin 
and calponin and inhibits proliferation as demonstrated by a lack of positive 
reaction with an antibody to PCNA. The diffuse staining for calponin in cells 
cultured in growth media is the result of reaction of the antibody with cytoplasmic 
calponin which is a different isoform, not associate with SM a-actin fibers. Scale 
bars are 50 jim. 
88 
5.2.3 Cell Encapsulation 
A precursor solution containing a total of 0.1 g/mL PEGDA and PEG-peptide-PEG along 
with 2.8 mM PEG-RGDS was prepared in HEPES buffered saline (HBS; 10 mM HEPES, 
100 mM NaCl, pH 7.4) and sterilized via filtration. Cells were trypsinized and 
immediately resuspended in the precursor solution at a concentration of 1.3 x 106 
cells/mL (10T1/2 LGPA), 10 x 106 cell/mL (SMC Low PQ), or 8 x 106 cell/mL (SMC 
High PQ). 10 ul of a 300 mg/mL solution of UV photoinitiator 2,2-dimethoxy-2-phenyl-
acetbphenohe dissolved in N-vinylpyrrolidone (NVP) was added per mL of the cell-
precursor solution mixture. The low viscosity mixture was gently agitated with a vortex, 
and the cell suspension rapidly pipetted into transparent cylindrical molds consisting of a 
6.4 mm diameter hollow plastic cylinder fitted with inner glass mandrels 3 mm in 
diameter. Long wavelength UV light (10 mW/cm2, 365nm) was applied to the hydrogels 
under constant rotation of the constructs for an average of 3 min/gel to produce uniform 
polymerization within and between gels. Long wavelength UV light has been 
extensively used at similar intensities and exposure times to induce rapid polymerization 
of PEGDA macromers with minimal concomitant cell damage in numerous tissue 
engineering applications[96,126-129,153,162,163]. 
5.2.4 Cyclic Mechanical Conditioning 
The polymerized constructs were removed from the molds and allowed to swell in media 
for 1 hr at 5% CO2 / 37°C. Ring samples were cut from each hydrogel construct and 
analyzed biomechanically as described below. The constructs were then transferred to 
the bioreactor chambers, and maintained under static conditions for one week in culture 
media. After one week of static culture, constructs were randomly assigned to static and 
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dynamic groups. The constructs in the static groups continued to be grown under static 
conditions during the remaining culture time. Over the course of three to seven days, the 
flow in each of the dynamic constructs was increased to the final conditioning 
parameters, which were at or near physiological levels depending on the experiment ( 
Table 5-1). A single pulsing pump was used to generate a pulsatile waveform with a 
pressure difference of 20 mmHg and pulse rate of 120 bpm. Wall shear stress was 
calculated from Equation 4-2 to be 7.5 dynes/cm2 (10T1/2 LGPA), 2 dynes/cm2 (SMC 
Low PQ), 4 dynes/cm (SMC High PQ) which are similar to, although slightly lower 
than^ physiological baseline wall shear of ~10 dynes/cm .[164] 
At each designated time point, samples from both the static and dynamic groups 
were harvested and cut into a series of rings for biochemical, biomechanical, and 
histological analyses. Wet weights of the constructs used for biochemical analyses were 
recorded and the samples were immediately frozen at-80°C. 
5.2.5 Biomechanical Testing 
Biomechanical testing was performed using a modification of the circumferential 
property testing techniques validated in Johnson et a/.[131] and Hiles et a/.[132] and 
described previously (4.3.3) Sections for biomechanical analysis were obtained by 
placing TEVG constructs on a glass mandrel and subsequently cutting the gels into thin 
rings using nylon monofilament sutures. Sample dimensions were obtained from digital 
images (inner and outer diameter) or using calipers (width). Material properties were 
then measured using an Instron Model 3340 materials testing device equipped with a 10 
N load cell (Instron). System control and data analysis were accomplished using Instron 
Series IX/s software. Custom mounting brackets provided uniaxial strain application at a 
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rate of 6 mm/min for the ring-shaped hydrogels. Each sample was run in triplicate and 
the stress-strain data was used to obtain the ultimate tensile stress (UTS) and average 
elastic modulus. The reported UTS for each sample was the maximum of the three 
measured failure stresses. Modulus was defined as the slope of the linear region of the 
stress-strain curve at a reference stress of 30 kPa. 
5.2.6 Biochemical Analyses 
Segments of each vessel, 100-200 mg wet weight, were analyzed for DNA, collagen 
content, and elastin content. The constructs were hydrolyzed in 700 uL of 0.1 N NaOH 
per 200 mg hydrogel wet weight for 36 hr at 37 °C. The samples were then centrifuged 
(10,000 x g for 10 min), and a 10 uL aliquot was taken from each sample for DNA 
quantification. Any material pelleted during centrifugation was resuspended by 
vortexing, and additional hydrolysis was carried out by transferring the samples to a 100 
°C oven for 90 min. This hydrolysis step served to solubilize collagen but not elastin 
fibers. Hydrolyzed samples were then cooled to room temperature and centrifuged to 
pellet elastin (10,000 x g for 10 minutes). The elastin pellet was washed three times with 
distilled water and stored at -80 °C. The supernatant was retrieved for collagen 
quantification. 
5.2.6.1 DNA Analysis 
Aliquots of the hydrolyzed samples retrieved for DNA analyses were neutralized. 
Sample DNA levels were then assessed using the Molecular Probes PicoGreen assay 
reagents (Invitrogen, Carlsbad, CA) and calf thymus DNA standards that had experienced 
the same base hydrolysis conditions as the constructs. DNA was translated to cell 
number using the conversion factor for murine cells of 6.6 pg DNA per cell[165] and 6 
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pg DNA per smooth muscle cell. [166] The conversion from DNA to cell number is 
commonly used to assess the cellularity of tissue engineered constructs. [126, 143, 167-
169] 
5.2.6.2 Collagen Analysis 
The supernatants retrieved for collagen quantification were subjected to acid hydrolysis 
in 6 N HC1 at 110 °C for 15-18 hr. For the 10T1/2 LGPA experiment, equal mass 
aliquots from each hydrolyzed static sample were pooled and the hydroxyproline (OHPr) 
content of this pooled sample was measured in duplicate by amino acid analysis (AAA 
Service Laboratory, Damascus, OR). Similarly, equal mass aliquots of hydrolyzed 
dynamic samples were pooled and the OHPr content of this pooled sample was measured 
in duplicate by amino acid analysis. Sample collagen content was calculated from 
measured OHPr levels using a conversion factor of 8 mg collagen per mg OHPr[170] and 
was normalized to cell number. 
In HCASMC PQ experiments the collagen content of hydrolyzed samples was 
determined using a colorimetric assay for OHPr.[171] In this assay, hydrolysis in 6N 
HC1 proceeded for 16 h at 110PC followed by evaporation of HC1 to dryness. All 
samples and OHPr standards were reconstituted in acetate-citrate buffer (pH 6.0) and 
then mixed with a chloramine-T reagent and incubated at room temperature for 20 min. 
After this time an aldehyde/perchloric acid solution was added to all samples followed by 
heating to 60°C for 15 min. Finally, the absorbance at 558 nm was read to determine the 
concentration of OHPr and conversion to collagen mass. 
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5.2.6.3 Elastin Content 
Elastin levels were determined according to the procedure detailed in Long et al. [158] 
Briefly, elastin pellets were digested in 6 N HC1 at 100 °C for 24 hr. Samples were then 
dried on a rotary evaporator, and the resulting free amino acids were dissolved in 100 ul 
of 0.1 M sodium citrate buffer (pH 5.0). Following addition of an equal volume of 
ninhydrin reagent, samples were boiled for 15 min, cooled, and their absorbance read at 
570 nm. Hydrolyzed a-elastin (Elastin Products Company, Owensville, MO) was used as 
the standard, and measured elastin levels were normalized to cell number. 
5.2.7 Histological Analysis 
Segments from each TEVG were harvested at designated time points in each study and 
immediately submerged in freezing media (Triangle Biomedical Sciences, Durham, NC). 
For the study involving 10T1/2 cells, 30 um frozen sections were immuno-stained to 
detect the presence of the SMC markers calponin and SM a-actin[172] to confirm that the 
10T-1/2 precursor cells were displaying a SMC-like phenotype. Briefly, fixation in 10% 
neutral buffered formalin (VWR Scientific, West Chester, PA) for 10 min was followed 
by a two-step blocking procedure (BEAT Block, Zymed, Carlsbad, CA) to prevent non-
specific interactions. Sections were next incubated with primary antibodies to either 
calponin (C2687, Sigma), or SM a-actin (A2547, Sigma) for 18 hr at 4 °C followed by 
the application of Peroxo-Block for 45 s to quench any endogenous peroxidase activity 
(Peroxo-Block, Zymed). Positive staining was visualized after successive incubations 
with a biotinylated secondary antibody for 30 min, an enzyme conjugate for 20 min, and 
an AEC substrate chromagen mixture for 10 min (Histomouse-SP, Zymed). Nuclei were 
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counterstained with hematoxylin and coverslips mounted using GVA mount (Zymed). 
Sections not exposed to primary antibodies served as negative controls. 
In studies with HCASMC, sections were analyzed using antibodies for ECM 
components including elastin (Elastin Products, PR385), collagen (Abeam, Cambridge, 
MA, ab24117), and fibronectin (Sigma, F3648). Frozen sections were cut and fixed as 
described above followed by blocking with a 3% BSA solution overnight. Incubation 
with primary antibodies for 8 h was followed by overnight application of a fluorescent 
secondary antibody (Invitrogen, Al 1008). All incubations were at 4°C. 
5.2.8 Detection of Matrix Metalloproteinase Activity 
Frozen sections of bioreactor specimen from the HCASMC High PQ study were analyzed 
for evidence of matrix metalloproteinase (MMP) activity using a method of in situ 
zymography.[173, 174] Samples of static and flow conditioned hydrogels cultured for 8 
weeks were analyzed. For the flow conditioned set, both differentiation and growth 
media sections were assayed. In this assay, glass slides were coated with an agarose 
solution mixed 1:1 with two different fluorescently labeled MMP substrates. Briefly, 
casein-fluorscien and gelatin-Oregan Green™ 488 (Molecular Probes, 1 mg/mL) were 
each mixed in equal parts with 1% agarose in Tris-HCl buffer (50 mM, pH 7.4) 
containing 10 mM Ca chloride and 0.05% Brij 35. The solution was coated onto slides in 
a manner similar to that used to make blood smears and the films allowed to solidify at 
room temperature protected from light. Frozen sections cut to 30 um were placed on the 
solidified films and covered with a drop of Tris-HCl buffer. For negative controls, 
sections were covered with Tris-buffer containing 10 mM 1, 10 phenanthroline. 
Coverslips were carefully placed on top of the samples and all slides incubated for 48 h at 
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37°C in a humidified chamber in the dark. After 48 h sections were inspected using a 
fluorescent microscope with black zones of substrate lysis indicating substrate breakdown 
viaMMPactivity.[173] 
5.3 Results and Discussion 
5.3.1 Biochemical Analyses 
5.3.1.1 Summary Cell and Matrix Data 
After culture, the degradable constructs exposed to physiological pulsatile flow 
conditioning were analyzed biochemically and compared to constructs cultured under 
static conditions. Mean results for all three study groups are summarized in 
Table 5-2 with plots from individual data sets following subsequently for observation of 
trends and variances within each study. For clarity, only data collected for the final time 
points in each study are reported in the summary table below. 
Table 5-2. Cell Number and ECM Content in TEVG 
10T1/2 
LGPA 
SMC 
LowPQ 
SMC 
High PQ 
Static 
Dynamic 
Static 
Dynamic 
Static 
Dynamic 
SMDM 
Dynamic 
SMGM 
Cell Number 
(Ccll/g wet weight) 
8.5xl05 * 
lOxlO5 * 
3.3xl06 * 
1.8xl06* 
1.5xl06 
1.4xl06 
l.lxlO6 
Elastin Content 
(ug/cell) 
(ug/g wcl weight) 
3.5xl0"5 
29 
3.5xl(r5 
35 
3.7X10-6 
12* 
2.7x1 0"6 
5 * 
7.6X10-6 
11 
lOxlO-6 
14 
9.5x10-6 
10 
Collagen Content 
(ug/cell) 
(ug/g wet weight) 
1.5X10-4 * 
179* 
1.8X10-4* 
133* 
5.5xl0"6 
13 
6.3xl0"6 
11 
1.5xl0-6 
21 
4.8x10"6 
11 
0.8xl(r6* 
31 * 
* indicates a statistically significant difference from other groups in the same study, 
p<0.05 
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The cell number in the dynamic constructs at final time point was significantly higher 
than that in the static constructs for the 10T1/2 LPGA and statistically lower in the SMC 
Low PQ studies (student t-test, p<0.05). For the 10T1/2 LPGA group this likely indicates 
that dynamic conditioning is enhancing cell survival/proliferation. This result is 
consistent with previous studies regarding the effects of pulsation on TEVG cell density 
at moderate strains[175]. However because the condition regimes for the SMC groups 
are similar and the primary differences in the two studies are degradable content and final 
culture time (5 wk for SMC Low PQ and 8 wk for SMC High PQ), analysis of the full 
data sets are necessary to draw further conclusions. 
Comparable amounts of elastin were measured in the static and dynamic constructs 
of all groups (p>0.05), indicating that mechanical conditioning did not effectively 
enhance elastin production/retention over the time of culture. Significant variability in 
terms of the effects of mechanical stimuli on elastin production has been reported in 
literature[124, 176], variability which may be due in part to differences in cell source, 
media additives[158], scaffold[158], and experimental time scale.[176] This being said, 
in the 10T1/2 LGPA study, the elastin levels in both the static and dynamic constructs 
compare well on a per cell basis with elastin levels characteristic of native arteries 
(roughly 8 x 10"5 ug/cell to 6.7 x 10"5 ug/cell, depending on the type of artery).[177, 178] 
Elastin levels in the SMC High PQ study was slightly lower than this value while that in 
the SMC Low PQ studies was an order of magnitude lower. Again, this could be 
primarily due to the time course (5 wk instead of 8 wk) of SMC Low PQ experiment. 
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In contrast to the elastin results, the dynamic constructs in the 10T1/2 LGPA study 
showed a 18.3% increase in the amount collagen per cell compared to static samples 
(students t-test, p < 0.05). These results are consistent with other studies that have 
demonstrated enhanced collagen production by vascular cells in response to mechanical 
stretch. Importantly, the collagen produced on a per cell basis in the dynamic constructs 
by week 8 (~1.8xl 0"4 jig/cell) compares favorably with per cell collagen content of native 
arteries, which ranges from roughly 3.1 x 10"4 ug/cell to 9.7 x 10"4 |j.g/cell[124, 177]. 
Since collagen is a primary structural protein responsible for the mechanical integrity of 
blood vessels under the high blood pressure and flows experienced in vivo, collagen 
levels approaching native tissue are critical for the success of TEVG. In the SMC groups 
there was again, no difference in the static versus dynamic culturing methods and 
notably, the magnitude of collagen production was much less than in the 10T1/2 LGPA 
study. 
5.3.1.2 Individual Study Data - Biochemical Analyses 
The data plots for the biochemical analyses of the 10T1/2 LGPA, SMC Low PQ, and 
SMC High PQ studies follow. All data are mean + SEM. 
Figure 5-2 displays the cell and ECM content information for the 10T1/2 LGPA 
study, which shows a significant increase in both 10T1/2 number and collagen content in 
dynamically culture TEVG over the 8 week study. In the SMC Low PQ study there are 
significantly fewer cells in dynamically cultured grafts, but no difference in ECM content 
after 5 weeks (Figure 5-3). 
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Figure 5-2. Cell Number and ECM Content for TEVG from the 10T1/2 LGPA 
Study. Biochemical analyses show an increase in cell number (A) and collagen 
content (B) in constructs cultured under pulsatile flow conditions at 120 bpm. 
Similar amounts of elastin Were measured in each group. * Indicates a statistical 
difference, cell number: p < 0.05, collagen content: p < 0.05. 
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Figure 5-3. HCASMC Cell Number and ECM Content in the Low PQ Study. 
There are statistically more cells in the statically cultured constructs at this 5 week 
time point (ANOVA, p<0.05). No significant differences exist between the culture 
conditions for either of these ECM components when normalized to cell number 
(ANOVA, p>0.05). 
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Results for the SMC high PQ study are slightly more complex since there were two 
time points and two media types for the latter part of the culture period. From this data, it 
is evident that there is a statistical increase in the number of HCASMC at the 4 week time 
point in dynamically culture TEVG compared to static controls (Figure 5-4). At the end 
of the experiment, however, this relationship is reversed with fewer cells in the dynamic 
constructs for the SMGM group and no difference when compared with the SMDM 
samples. There is a general downward trend in cell number for the two HCASMC 
studies with final cells number in the range of 10-20% of the seeded values. 
4x106 
• Week 4 
• SMGM Week 8 
0 SMDM Week 8 
Static Dynamic 
Figure 5-4. Number of HCASMC in the High PQ Study. All groups are statistically 
different from each other except Dynamic Week 8 SMDM which is similar to both 
Static Week 4 and Dynamic Week 8 SMGM (ANOVA, p<0.05). 
99 
Elastin content on a per cell basis is significantly improved over the course of this 8 
week study (Figure 5-5). Collagen synthesis and retention, however, remains relatively 
unaffected with the exception of the Dynamic SMDM group which seems to significantly 
increase collagen content compared to other groups. 
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Figure 5-5. Elastin and Collagen Content for SMC High PQ Study, indicates 
statistically different from Static Week 4 group, # is statistically different from Flow 
Week 4, and $ is different from Dynamic Week 8 SMDM (ANOVA, p<0.05). 
5.3.2 Biomechanical Analyses 
To monitor the changes in construct mechanical properties with time, biomechanical 
analyses were conducted. As shown in Figure 5-6, there is a significant decrease in 
TEVG stiffness during the first 4 weeks of culture for the 10T1/2 LPGA samples (A) and 
the dynamic group from the SMC High PQ study (C, ANOVA, p<0.05). For the final 4 
weeks, the dynamic constructs in each case recover to values that are no longer different 
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from the initial time point (p>0.05), while the static group containing 10T1/2 cells 
continues to decline (p<0.05). Static TEVG in the SMC High PQ study remain 
unchanged throughout the 8 week culture period. The constructs in the SMC Low PQ 
study (B) do not match this trend and instead demonstrate a significant increase in 
stiffness over the 5 week study. The construct UTS (Figure 5-7) increases in the SMC 
Low PQ study, but remains unchanged in other groups. This is not unexpected as the 
UTS measurements in this analysis typically have large within group variations. 
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Figure 5-6. Elastic Moduli of Bioreactor TEVG. For 10T1/2 LGPA (A) and 
HCASMC High PQ (C) groups there is a general trend of decreasing stiffness over 
the first 4 wk of culture followed by an increase to the end of the experiment. This 
is not the case in the Low PQ SMC study where the second time point is statistically 
higher for both static and dynamic groups. "Indicates statistically different from the 
initial time point (ANOVA, p<0.05). 
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Figure 5-7. Ultimate Tensile Stresses for Bioreactor TEVG. There is a statistical 
increase in the UTS for constructs in the SMC Low PQ study (B, ANOVA, p<0.05), 
while all other groups remain unchanged during culture. 
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Another primary observation from these mechanical analyses is the overall decrease 
in modulus and UTS values from the 10T1/2 study to the HCASMC studies. For 
example, the modulus in 10T1/2 LGPA samples ranges from -66-73 kPa while in the 
HCASMC studies the range is -9-27 kPa. This is a dramatic difference, but was 
expected since the nearly 10-fold increase in cell number adds significant non-fluid mass 
to the hydrogel formulation prior to initiation of the crosslinking event. Cells effectively 
function to disrupt the final network structure and thereby decrease the resultant hydrogel 
stiffness. This lower stiffness can be a drawback since more compliant gels do not 
adhere as tightly to graft chamber ports and consequently leak at high pressures and large 
pressure differentials. For that reason, the HCASMC studies were conducted at sub-
physiological flow conditions. 
Analysis of these results suggests that the initial decrease in modulus observed for 
the 10T1/2 LGPA and SMC High PQ studies may be due to a reduction in hydrogel 
crosslinking density as the result of degradation of the collagenase sensitive peptide 
linking the PEG chains present in the constructs. With increasing time in culture, the 
moduli of the static hydrogels continued to deteriorate, perhaps due to a continued 
degradation of the network that was not matched by new protein production. It could 
also be proposed, then, that if the HCASMC in the SMC Low PQ study degrade the low 
percentage PEG-PQ-PEG hydrogel at a very slow rate, this would account for the lack of 
an initial decrease in mechanical properties for hydrogels in the SMC Low PQ study. 
5.3.3 Histological Analysis 
Although TGF-pi was added to the cell culture media to induce SMC-like phenotype in 
the encapsulated 10T-1/2 SM progenitor cells [179], it was still important to verify that 
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the encapsulated progenitor cells were indeed displaying SMC-like phenotype. Calponin 
and SM a-actin are two standard markers used to identify cells expressing a SMC 
phenotype[172, 180]. Immunohistochemical analyses of both static and dynamic 
constructs revealed comparable expression of calponin and SM a-actin (Figure 5-8) in 
each. These results indicate the expression of a SMC-like phenotype under the current 
culture conditions and validate the use of these progenitor cells for applications in 
vascular graft regeneration. 
! i. 
• • • : * , * : 
Figure 5-8. Immunohistochemical Staining for SMC Markers in 10T1/2 Cells. 
Immunohistochemical analysis confirms the presence of the smooth muscle cell 
markers calponin (left) and smooth muscle a-actin (middle) in sections from TEVGs 
cultured in this study. These representative samples demonstrate the level of 
staining that was seen in both the mechanically stimulated and static groups. The 
red color indicates reaction with the primary antibodies, which were not applied in 
the negative control (right). Scale bars are 10 um. 
Immunofluorescent staining of hydrogel constructs after 8 wk of culture in the SMC 
High PQ study reveal homogenous cell distribution in all culture groups (Figure 5-9). 
This is an important observation that indicates that there are no diffusion limitations 
within the hydrogels which would selectively jeopardize cell viability. ECM proteins 
were localized to the immediate pericellular region in all groups consistent with the low 
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magnitude of protein detected by biochemical assays (5.3.1). The low accumulation of 
EMC molecules could be the result of the permissive hydrogel network structure, which 
is protein non-fouling by design and has a relatively large mesh size (Table 2-1). Nascent 
proteins may actually be escaping from the hydrogel during culture, though media 
samples would need to be analyzed in order to confirm this assumption. Finally, a 
differentail interference contrast (DIC) image reveals the topography of a hydrogel 
section (Figure 5-9, D) and shows that encapsulated HCASMC exhibit a mostly round 
morphology, which may have implications in the decreased cell viability with time in 
culture.[181] 
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Figure 5-9. IHC Sections of Demonstrating HCASMC Distribution and 
Morphology in Bioreactor Samples. There was no obvious difference in staining or 
cell distribution in dynamic (A) or static (B) nor in SMDM versus SMGM (not 
shown). Staining for ECM components (Fibronectin is shown) indicate only 
pericellular localization (C). The DIC image (D) reveals cell morphology within the 
hydrogel section. 
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5.3.4 Detection of Matrix Metalloproteinase Activity 
In a final assessment, in situ zymography was used to detect the presence of MMP within 
the TEVG constructs. Preliminary results indicate that HCASMC have indeed 
synthesized enzymes capable of degrading a gelatin substrate, but not casein (Figure 
5-10). This would imply the presence of gelatinases such as MMP 2 and MMP 9 and is 
consistent with the targeted recognition for the GGGPQGIWGQGK peptide.[156] The 
presence of the degrading enzymes is a good indicator of the potential of HCASMC to 
remodel their surrounding hydrogel matrix in route to organization of a mature tissue 
construct. 
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Figure 5-10. MMP Activity in Bioreactor Samples. Black areas in the location of 
the hydrogel sample in the upper left image demonstrate MMP activity and cleavage 
of the gelatin substrate. A lack of cleavage of the casein substrate indicates that 
MMP produced are not active against this protein. Phase contrast images are 
included for reference and "h" indicates location of the hydrogel, while "s" indicates 
location of fluorescent substrate. Scale bar is 100 urn. 
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5.4 Conclusions 
In conclusion, this chapter summarizes a series of initial bioreactor investigations. 
Studies demonstrate the utility and flexibility of the designed flow system to 
accommodate a range of conditioning parameters. When combined with the tunable, 
biomimetic PEGDA hydrogel, the system offers great potential for evaluating the 
individual effects of biochemical and mechanical factors on TEVG development. Results 
herein indicate that mechanical conditioning can positively influence the cell and ECM 
content of hydrogel scaffolds and also modulate mechanical properties. These impacts 
are especially "evident with flow conditions close to physiological levels. In addition to 
flow parameters, initial cell density and degradable matrix content also influence 
outcomes of bioreactor constructs. In summary, this system will serve as an important 
tool for the analysis of tissue engineered vascular graft development and maturation. 
6. Conclusions and Future Directions 
6.1 Thesis Summary 
The prevalence of coronary artery disease combined with a paucity of suitable vessel 
substitutes act as driving forces for cardiovascular tissue engineering research, and as 
such, have served as motivation for this thesis. The global objectives for this work were 
two-fold. First, a thorough characterization of poly(ethylene glycol) diacrylate (PEGDA) 
hydrogels was warranted. This evaluation focused primarily on the network structure of 
the hydrogel material and On its mechanical properties (Chapter 2). Subsequent studies in 
Chapter 3 explored the effect of these hydrogel properties the material's ability to serve 
as a tunable substrate for vascular smooth muscle cells. A special focus is placed on the 
ability to independently tune the hydrogel's biochemical properties (e.g. cell adhesivity) 
and biornechanical properties (e.g. stiffness) in an effort to identify parameters most 
important to cell-substrate interaction. 
The second primary objective was to design, develop, and evaluate a pulsatile flow 
culture system for tissue engineered vascular graft constructs that was capable of 
achieving physiologically relevant fluid flow parameters. It was necessary that the 
system be amenable to long term culture of moderate to large sample size experiments in 
order to maximize the impact on data acquisition. Details of the design and 
characterization of the pulsatile flow bioreactor system are included in Chapter 4. In 
Chapter 5, a series of experiments with cell-seeded tissue engineered vascular grafts 
(TEVG) demonstrated the utility and versatility of this system. 
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6.2 Conclusions 
6.2.1 PEGDA Hydrogels as Scaffolds for Vascular Smooth Muscle Cells 
Bulk properties of PEGDA hydrogels formed from a range of polymer molecular weights 
and solution concentrations were characterized. Resultant materials demonstrate tunable 
stiffness and strength, and transport properties (e.g. mesh size and crosslink density) that 
are appropriate for supporting viability of encapsulated cells. Hydrogel stiffnesses 
ranging from ~ 10-400 kPa are of the appropriate compliance to be tailored to match the 
mechanical properties of a variety of tissues from muscle to cartilage. Even more recent 
work has revealed hydrogel formulations with moduli in the MPa range, making them 
suitable substitutes for hard tissues such as bone. 
Human coronary artery smooth muscle cells (HCASMC) seeded on top of these 
PEGDA hydrogels exhibit changes in attachment, proliferation, and morphology that can 
be directly correlated to the rigidity of the substrate material. In general, stiffer materials 
encourage greater attachment, a higher rate of proliferation, and the development of a 
mature, spread morphology. Finally, these responses were shown to be independently 
modulated by changing either the hydrogel material properties or the peptide directed 
bio-adhesiveness of the substrate. 
6.2.2 A Pulsatile Flow Tissue Bioreactor 
The tissue bioreactor presented in this work is capable of imparting physiological fluid 
flow (120 mL/min), shear (5-10 dynes/cm2), pressure waveforms (120/80 mmHg), and 
pulse rates (60 or 120 bpm). Evaluation of the bioreactor system shows good 
reproducibility in flow parameters, and importantly that the system has good "ease of 
use", which is critical for long term experiments requiring frequent maintenance. Cell-
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laden hydrogel constructs cultured for up to 8 wk in this system responded to mechanical 
stimulation with increases in cell and extracellular matrix (ECM) content and positive 
modulations to material properties. Though the magnitude of ECM accumulation is quite 
low, changes in hydrogel stiffness and the presence of degrading enzymes indicate that 
the encapsulated vascular cells are working towards a more biologically appropriate 
surrounding. While all the appropriate parameters for TEVG culture are not yet 
understood, this device will serve as an important tool in the development of a small 
diameter vessel substitute. 
6.3 Further Investigation of Biomimetic Hydrogels 
There are numerous potential applications of biomimetic PEGDA hydrogels to studies of 
fundamental cell-substrate interactions. For instance, it would be extremely interesting to 
delve more into the underlying mechanism of cellular response to substrate rigidity by 
probing cells with monoclonal antibodies to specific adhesive moieties (integrin and 
otherwise) to determine which are most prominent on soft and stiff hydrogels, 
respectively. 
In light of our interest in TEVG development, however, it may be most appropriate 
to expand these investigations to 3D cell environments. As shown in the current work 
(Figure 6-1) and elsewhere,[117] vascular cells, which are highly spread in vivo and on 
2D substrates are rounded in the current hydrogel formulations and have an apparent 
decreased viability with time in culture. This suggests that it may be necessary to 
enhance the biochemical signals incorporated in the hydrogel to promote greater cell 
interaction. Of particular benefit would be functionalities which could also stimulate the 
synthesis and retention of ECM molecules. 
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Figure 6-1. Photomicrograph of HCASMC in a Degradable PEGDA Hydrogel. 
Cells are evenly dispersed throughout the hydrogel matrix (left) after 8 wk in 
culture and display a rounded morphology. An unseeded hydrogel is included as a 
reference (right). Scale bar is 100 fim. 
6.4 Towards an Implantable Tissue Engineered Vascular Graft 
Though most efforts in TEVG development thus far have focused on reproduction of the 
medial layer of the blood vessel, it is widely accepted that successful vascular graft 
substitutes must also contain an intact endothelium. In native blood vessels, the intima 
consists of a monolayer of endothelial cells (EC) which helps prevent platelet adhesion 
and aggregation, and regulates vessel permeability, vascular smooth muscle cell 
behavior, and homeostasis.[49, 72, 89] As such the endothelium serves as important 
mediator in the vessel - blood interaction in vivo. To further our work towards an 
implantable TEVG and to increase the blood compatibility of poly(ethylene glycol)-based 
tissue engineered grafts, efforts should be made to seed EC on the luminal surface of 
tubular hydrogels. This attachment can be accomplished by functionalizing the luminal 
surface with a second layer of hydrogel material that contains EC-specific peptide 
sequences. Potential sequences include the laminin-derived peptides YIGSR and 
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IKVAV, which have been shown to promote EC attachment in non-integrin mediated 
processes [182], and REDV, which is an EC adhesive sequence derived from the protein 
fibronectin and acts via the a4|31 integrin receptor.[38, 40, 46-48] Importantly, literature 
referenced here and elsewhere shows that these ligands are not adhesive for platelets. 
Once the hydrogels have been functionalized to permit EC attachment, the tissue 
culture bioreactor developed in the current work can be modified to seed cells. As shown 
in Figure 6-2, use of the peristaltic pump and custom graft chamber allow a cell 
suspension to be re-circulated through the TEVG constructs, effectively depositing cells 
on the luminal surface of the hydrogels. In recent work in our lab, we used this modified 
system to seed human coronary artery endothelial cells onto metal stents that had been 
deployed within tubular PEGDA hydrogels.[183] Cells were seeded under low flow 
conditions for 1 week and then allowed to proliferate to confluence. 
Graft Chamber with 
Gas Vents 
Figure 6-2. Bioreactor Flow Loop Modified for Endothelial Cell Seeding. The 
peristaltic pump and graft chamber can be used to seed suspensions of endothelial 
cells onto the luminal surface of PEGDA hydrogels. 
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Establishment of a functional endothelial layer will not only increase the blood 
compatibility of the TEVG, but also has potential for regulating and directing the 
encapsulated smooth muscle cells. Working in conjugation, the cells will be able to 
reorganize the available PEGDA hydrogel material and newly synthesized tissue matrix 
in order to form a biologically functional blood vessel substitute. 
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